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ABSTRACT 
Background: Sphingolipids are a broad class of molecules with the double role of 
cell membranes components and intra/extra cellular signal mediators, controlling 
proliferation, differentiation, stress survival and apoptosis. Ceramide (Cer), the core 
of complex sphingolipids, can undergo deacylation giving rise to sphingosine and 
sphingosine-1-phosphate (S1P). This latter exerts a pro-survival and proliferative 
activity, as opposed to Cer, which promotes cell cycle arrest and apoptosis. Retinal 
degeneration and in particular Retinitis Pigmentosa (RP) are associated to Cer 
accumulation and cell death induction. In a murine model of RP (rd10 mutant 
mice), it has been demonstrated that inhibition of Cer synthesis and accumulation, 
blocking serine palmitoyltransferase (SPT) with Myriocin, rescues retinal 
photoreceptors, especially cones, from degeneration. 
Aim: Our aim is to target sphingolipid metabolism to reduce retinal photoreceptor 
damage, in a cone photoreceptors cell line. In particular, promoting S1P 
intracellular increase by S1Plyase inhibition and Cer  depletion through SPT 
inactivation. 
Methods: Murine 661W cone-like cell line were treated with 75µM 2-acetyl-4(5)-
(1(R),2(S),3(R),4-tetrahydroxybutyl)-imidazole (THI), an inhibitor of S1Plyase, for 2 
hours; next, cells were starved and treated with 1mM H2O2 for different times. Cell 
growth curve was determined by MTT assay and viability with Trypan blue. TUNEL 
assay and FRAP test were employed to verify, respectively, apoptosis degree and 
antioxidant-intrinsic power. Sphingolipid intracellular amounts were measured 
through LC-MS analysis. ERK1/2 and Akt/PKB phosphorylation, Bcl-2/Bax ratio 
and Nrf2 expression was evaluated by Western blotting with specific antibodies. 
Real time-PCR was performed to establish HO-1 and S1P receptors transcript 
changes upon THI and oxidative stress treatments. Exogenous S1P (100nM) and 
Myriocin (10µM) were also employed, respectively 1 hour and 5 hours before H2O2, 
to antagonize oxidative stress effect on photoreceptors. Lastly, we screened 30 
new synthetic compounds to determine their ability in inhibiting SPT, through an 
enzymatic activity assay. 
Results: We show that enhanced stability of S1P, obtained through THI 
administration, reduces inhibitory starvation and H2O2 effect on cell proliferation 
and viability. In particular, through THI ability to reverse stresses-induced ERK1/2 
dephosphorylation and Akt phosphorylation on Ser473. We focused our 
investigations on oxidative stress, finding that THI counteracts H2O2-induced 
apoptosis increasing Bcl-2/Bax ratio and antioxidant-intrinsic power modulating 
Nrf2/HO-1 pathway. Furthermore, THI differentially induces S1P receptors 
transcript expression, showing the major effect on S1P4 and S1P5. In addition, low 
exogenous S1P improves 661W proliferation, viability and antioxidant response, 
whereas higher concentration leads to S1P receptors saturation. Myriocin 
treatment, either alone or in combination with THI, rescues photoreceptors from 
H2O2-induced oxidative stress and drastically reduces all Cer pools. 
Simultaneously, we selected three compounds with inhibitory activity on SPT, 
showing an IC50 values ranging from 17.71µM to 40.41µM. 
Conclusions: We conclude that S1P stabilization and, in general, sphingolipid 
metabolism manipulation can be considered a therapeutic target in order to 
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promote photoreceptors survival under different stress conditions, such as 
oxidative stress.  
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RIASSUNTO 
Introduzione: gli Sfingolipidi sono una vasta famiglia di molecole con il duplice 
ruolo di componenti strutturali di membrane e mediatori intra ed extra cellulari. 
Sono implicati nel controllo di proliferazione, differenziazione e sopravvivenza 
cellulare ma anche di fenomeni legati alla morte, tra cui l’apoptosi. Ceramide (Cer), 
alla base degli sfingolipidi complessi, può andare incontro a deacilazione 
generando sfingosina e sfingosina-1-fosfato (S1P). Quest’ultimo è considerato un 
mediatore di sopravvivenza e proliferazione cellulare, in opposizione a Cer, che 
promuove arresto del ciclo ed apoptosi. La degenerazione retinica ed, in 
particolare la Retinite Pigmentosa (RP) sono associate all’accumulo di Cer ed 
all’induzione di morte cellulare. L’inibizione della sintesi e dell’accumulo di Cer, 
inattivando la serina palmitoiltransferasi (SPT) attraverso l’utilizzo di Miriocina, è 
stata dimostrata essere coinvolta nel recupero morfologico e funzionale dei 
fotorecettori retinici, in particolare dei coni, in un modello murino di RP (mutante 
rd10). 
Scopo: Il nostro scopo è di intervenire sul metabolismo degli sfingolipidi per ridurre 
il danno di fotorecettori retinici, attarveso l’utilizzo di una linea cellulare di 
fotorecettori coni. In particolare, promuovendo l’aumento di S1P intracellulare, 
tramite l’inibizione dell’enzima S1P liasi, e la riduzione di Cer attraverso 
l’inattivazione di SPT. 
Metodi: le cellule murine 661W, una linea di fotorecettori (coni), sono state trattate 
con 2-acetil-4(5)-(1(R),2(S),3(R),4-tetraidrobutil)-imidazolo (THI) 75µM, un inibitore 
dell’enzima S1Pliasi, per 2 ore; quindi, le cellule sono state sottoposte a 
deprivazione di siero e trattate con H2O2 1mM per differenti lassi di tempo. La curva 
di crescita di queste cellule è stata determinata attraverso il saggio MTT e la vitalità 
con Typan blue. Il saggio TUNEL e il FRAP test sono stati impiegati per verificare, 
rispettivamente, il grado di apoptosi e il potere antiossidante intrinseco dei 
fotorecettori. I contenuti intracellulari di sfingolipidi sono stati misurati attraverso 
l’analisi LC-MS. La tecnica del Western blotting, attraverso l’impiego di anticorpi 
specifici, è stata utilizzata per valutare la fosforilazione di ERK1/2 e Akt/PKB, il 
rapporto tra Bcl-2/Bax e l’espressione proteica di Nrf2. Attraverso Real time-PCR, 
le modulazioni nell’espressione dei trascritti di HO-1 e dei recettori di S1P sono 
stati valutati in seguito a stress ossidativo e trattamento con THI. S1P esogeno 
(100nM) e Miriocina (10µM) sono stati impiegati, rispettivamente 1 ora e 5 ore 
prima H2O2, per antagonizzare l’effetto dello stimolo ossidativo sui fotorecettori. In 
fine, abbiamo esaminato 30 composti di nuova sintesi per determinare la loro 
capacità inibitoria su SPT, attraverso un saggio di attività enzimatica. 
Risultati: i nostri risultati mostrano che l’aumentata stabilità di S1P, ottenuta 
tramite l’utilizzo di THI, è in grado di ridurre l’effetto inibitorio sulla proliferazione e 
la vitalità cellulare, dato dalla deprivazione di siero e dal trattamento con H2O2. Il 
pretrattamento con THI, infatti, antagonizza la de-fosforilazione di ERK1/2 e la 
fosforilazione di Akt su Ser473, indotte dagli stimoli di morte utilizzati. Abbiamo, 
quindi, focalizzato la nostra ricerca sugli effetti dello stress ossidativo, 
evidenziando che THI si contrappone all’induzione dell’apopstosi tramite l’aumento 
del rapporto Bcl-2/Bax e influenza il potere antiossidante intrinseco dei fotorecettori 
modulando la via di segnale di Nrf2 e HO-1. Inoltre, THI aumenta l’espressione dei 
recettori di S1P, mostrando un effetto maggiore sui recettori S1P4 e S1P5. Inoltre, 
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abbiamo osservato che basse concentrazioni di S1P migliorano la proliferazione, la 
vitalità e la risposta antiossidante di cellule 661W, mentre alte concentrazioni 
portano alla saturazione dei recettori.Il pretrattamento con miriocina, sia da solo 
che in combinazione con THI, protegge i fororecettori dallo stress ossidativo e 
riduce drasticamente i livelli intracellulari di tutte le specie di Cer. Parallelamente, 
abbiamo selezionato tre composti con attività inbitoria su SPT, determinando i 
rispettivi valori di IC50 che sono risultati essere compresi tra 17,71µM e 40,41µM. 
Conclusioni: possiamo quindi concludere che la stabilizzazione di S1P e, più in 
generale, l’azione sul metabolismo degli sfingolipidi è da considerarsi un target 
terapeutico per promuovere la sopravvivenza fotorecettoriale in differenti condizioni 
di stress, tra cui lo stress ossidativo.   
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1.1 Retina 
The retina, or eye nervous tunic, is placed in the posterior segment of the 
eye, between the vitreous body and the vascular tunic. It is a multilayer 
structure mostly comprised of neural cells and crossed by Müller cells, 
representing the retinal glia.  
It is the neural portion of the eye and belongs to the central nervous 
system, although its peripheral anatomic position. It structurally arises from 
the diencephalon, which is connected through the optic nerve, that refolds 
originating the optic vesicle, and consequently the optic cup: whose inner 
wall corresponds to the retina whereas the outer becomes the pigment 
epithelium (RPE). The epithelium is made up of a tight-junction, connected, 
single cell layer in close contact with the external retinal neurons, 
photoreceptors, and separated from the choroid by the Bruch's membrane, 
the blood-retina barrier. RPE apical membrane and processes surround the 
light-sensitive outer segments of photoreceptors establishing a tight 
structural and functional relationship. Because of high melanin content, it 
represents a sort of shield for entering light; furthermore, its thigh relation 
with photoreceptors involves it in several metabolic activities with critical 
relevance in photoreceptors survival, such as: release of neurotrophic 
factors and nutrients and daily phagocytosis of outer segments to prevent 
retinoids derivates and oxidized lipid accumulation, in RPE cells also visual 
cycle occurs  [1].  
Five are the typologies of neurons present in the retina. Starting from the 
pigment epithelium we find: photoreceptors, the light-sensitive cells; bipolar 
cells and ganglion cells (RGCs), whose axons bundle to form the optic 
nerve. The nervous signal arises in photoreceptors after light stimulus and 
goes through this three-neurons chain, crossing the optic nerve, directly to 
the visual cortex in the central nervous system. The other two kinds of 
neural cells are the horizontal and the amacrine; they are, respectively, 
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responsible for lateral interactions of photoreceptor-bipolar cells and 
bipolar-ganglion cells synapses, originating the so called ribbon synapses. 
The neural retina can be divided into six layers distinguished by the kind or 
the structure of cells that it houses: photoreceptors outer segments layer; 
outer nuclear layer, with photoreceptors nuclei; outer plexiform layer, where 
photoreceptors make synapse with bipolar and horizontal cells; inner 
nuclear layer, containing bipolar, horizontal and amacrine nuclei; inner 
plexiform layer, where there are the synapses of photoreceptors or 
amacrine cells with ganglion cells and finally ganglion cell layer, occupying 
from their nuclei (Fig. 1.1) [2]. 
 
Fig. 1.1: Schematic representation of neural retinal cell layers. Modified from: 
www.webvsion.med.utah.edu 
1.1.1 Photoreceptors 
The photoreceptors are the retinal neurons, where the phototransduction 
cascade is activated. Their cellular structure could be described dividing it 
into two major parts: an outer segment, specialized in detecting photons 
signal and constituted of stacks of disk membranes in which cromophores 
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are localized, and an inner segment, containing the nucleus and other 
cellular organelles necessary for cell metabolism. 
Photoreceptors can be distinguished in two classes: rods and cones. Their 
complementarity is described in several traits in which they differ: number, 
retinal distribution, structure, function and sensitivity to light . 
Due to their sensitivity to light, rods, with their slim and protracted structure, 
are able to detect a single incoming photon and therefore their function 
consists in allowing vision under dark-dim conditions at night (scotopic 
vision). On the other hand, cones, robust conical-shaped and shorter than 
rods, are up to 100-fold less sensitive than rods but show an extraordinary 
ability in adjusting their sensitivity and are fundamental for colour 
perception in our visual image (photopic vision). Their specific and opposite 
roles, bring to rods saturation in bright light and to inactivation of cones in 
darkness. [3]. They differ also in number and retinal distribution, cones are 
mainly concentrated, organized in a hexagonal mosaic, in the central area, 
the fovea, and do not exceed 6-7 million of cells. On the other hand rods 
are distributed all across the retina and, even if they maintain a regular 
architecture, they do not follow a real defined distribution. Rods are much 
more numerous, they can reach a total of up to 120 million of cells [4]. 
1.1.2 Phototransduction 
Phototransduction is the signal transduction pathway whereby incoming 
light is transformed in electrical response. The key proteins starting this 
mechanism are retinal chromophores, rhodopsin in rods and  three different 
wavelength sensitive-opsins in cones, long wavelength sensitive for red (L-
cones), middle wavelength sensitive for green (M-cones) and short 
wavelength sensitive for blue (S-cones). Absorption of a photon by retinal 
cromophores cause the isomerization of 11-cis retinal to all-trans retinal 
and the start of the phototransduction cascade. This conformational change 
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brings to the dissociation of the prostatic group from the opsin, that binds 
and stimulates a GTP binding protein, transducin, inducing the activation of 
its α-subunit. The activated transducin subunit binds to the enzyme cGMP 
phosphodiesterase (PDE) that gradually hydrolyzes cytoplasmatic cGMP 
and leads to the closure of cGMP-gated channels on the plasma 
membrane (PM) (Fig. 1.2). These channels maintain a steady inward 
current in darkness (“dark current”) and depolarize the cell sufficiently (dark 
membrane potential at ~−30 mV) to sustain synaptic-transmitter 
(glutamate) release. The light-induced closure of the cGMP-gated channels 
produces a reduction of positive ions concentration (Na+ and Ca++) inside 
the outer segment and a consequent membrane hyperpolarization. The 
generated electric current crosses the photoreceptor body up to the 
synaptic terminal, reducing or stopping glutamate release and secondary 
neurons inhibition [5].  
 
Fig. 1.2: Schematic representation of phototransduction cascade. Original 
source: Yau et al 2009 
 
Along with phototransduction, visual cycle occurs in RPE photoreceptors-
adjacent cells. This fundamental process implicated in cromophores 
recycling, covers an important role, not only in guaranteeing a prompt 
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transformation of all-trans retinal back in 11-cis retinal, necessary for an 
efficient response to light, but also in protecting photoreceptors against bis-
retinoids and adducts possible accumulation [6]. 
1.1.3 Retinal degenerations: Retinitis Pigmentosa 
Due to its complexity, the retina is exposed to several kind of 
degenerations, generally distinguishable by the first kind of cell layer 
affected but often extended to others retinal structures. This underlies how 
critically important is the equilibrium between all cells that constitute the 
retina. Some of the most studied pathologies are linked below. 
Age-related macular degeneration (AMD), in which photoreceptors placed 
in the macula, the central area of the retina, start to degenerate in later-life, 
seems to be related both with neovascularization and RPE dysfunctions 
that leads to the accumulation of extracellular deposits between epithelial 
cells and Brunch’s membrane. This induces the block of nutrients and 
regulatory substances fluxes, which are vital for RPE and photoreceptor 
survival. Glaucoma, characterized by an elevation of intraocular pressure 
(IOP), shows a degeneration of RGCs and optic nerve head, rapidly 
translated in loss of visual fields. Diabetic retinopathy is tightly connected 
with neovascularization, caused by hyperglycaemia-induced microvascular 
occlusion. As well as in AMD, new vessels invade RPE and branch out 
inside the neuroretina [7]. Retinitis Pigmentosa (RP) is one of the most 
common forms of inherited pathologies that affects retinal tissues and, 
probably, the most complex and heterogeneous studied. RP includes a 
group of inherited retinal disorders, in which loss of photoreceptors and 
retinal pigment deposits are observed. It, characteristically, starts with rod 
loss, linked to poor night vision, and then evolves in progressive cone 
degeneration causing the reduction of mid-peripheral field of vision. Still-
active area, gradually, shrinks into a small central region corresponding to 
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macular cones and defining the typical tunnel vision described in these 
kinds of pathologies. Final-point patients lose the central vision in later-life 
and can reach legal and, at last, total blindness. RP could be classified in 
three wide groups: simple, when only eye dysfunctions are identified; 
syndromic, in the case of, also, non-ocular disease are implicated and 
systemic, related to pathologies in which retinal degeneration becomes less 
relevant than other organs involvement. Some of the most studied 
syndromes linked to RP are Usher’s syndrome, Bardet-Biedl syndrome, 
Leber’s congenital amaurosis and Refsum’s disease [8] [9]. 
1.1.3.1 Genetic mutations  
Three are the main kinds of inherited transmission in RP, almost of 
monogenic mutations (deletions, insertions or substitutions): autosomal-
dominant (20-25%), autosomal-recessive (15-20%) and X-linked (10-15%). 
The residual percentage is represented by non-genetic factors, non-
Mendelian inheritance (for example mitochondrial or de novo mutations) 
and complex inheritance. Some patients present digenic RP (one 
modification in RDS gene, encoding peripherin, and another in ROM1 
gene, encoding retinal outer segment membrane protein 1) [10]. 
Since 1984, when the first polymorphism was associated to RP [11], more 
than 50 genes, linked to non-syndromic RP, were mapped and identified 
(Tab. 1.1).  
Introduction 
15 
 
RP Category Total Genes and Loci Identified Genes 
Autosomal dominant 
(adRP) 
20 19 
Autosomal recessive 
(arRP) 
32 29 
X-linked (XLRP) 5 2 
Tab. 1.1: Number of genes associated to non-syndromic retinitis pigmentosa. 
Original source: https://sph.uth.edu/retnet/sum-dis.htm#D-graph 
 
Genetic mutations resulting in photoreceptors degeneration can affect 
genes implicated in several functions: renewal and shedding of outer 
segment, as mutation in peripherin/RDS gene, one of the earliest protein 
linked to RP [12, 13]; visual transduction cascade, as mutated 
phosphodiesterase catalytic subunits α (PDE6A) and β (PDE6B) and five 
different mutations of rod cGMP-gated channel, both kind of mutations 
related to arRP; metabolism of retinol, as mutation in cellular retinaldehyde-
binding protein (CRalBP) or in retinal pigment epithelium protein (RPE65) 
[14]. One of the most studied retinal protein is the rhodopsin (RHO), the 
first found to be mutated in RP [15] and the responsible for almost 25% of 
adRP cases. Many different mutations, divided in six classes, are related to 
this protein giving rise to patients extensive clinical heterogeneity [16]. 
Among all numerous mutations causing arRP one is particularly relevant for 
our study. In RP26, an autosomal recessive locus, it was identified a 
mutation linked to CERKL gene, encoding a modified ceramide kinase-like 
protein able to augment the sensibility of retinal cells to apoptotic stimuli. 
This outcome determines the first link between human genetic modification 
of sphingolipid metabolism and the onset of retinal degeneration [17].  
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1.1.3.2 Mechanisms of photoreceptors degeneration  
Photoreceptors vulnerability is particularly enhanced by their peculiar 
physiology and biochemistry, keeping them on a fine line between survival 
and death, where any defect can be crucial in defining their fate. The first 
factor that subjects photoreceptors to risks is light exposure. In presence of 
oxygen, the ionizing effect of light is boosted and reactive oxygen and 
nitrogen species (RONS) are generated especially by photosensitizing 
molecules, such as retinoids. Both retinoid derivates and RONS excessive 
accumulation can cause photoreceptor degeneration. Another source of 
vulnerability in photoreceptors is represented by their lipid-rich outer 
segment membranes, especially for very-long-chain polyunsaturated fatty 
acid (PUFA). PUFAs oxidation gives rise to highly reactive electrophilic 
aldehydes, including malondialdehyde (MDA) that starts destructive free 
radical chain reactions. Moreover, retinal protein mutations, especially 
linked to RHO, cause protein misfolding activating the unfolded protein 
response (UPR) in the endoplasmatic reticulum (ER). All this events can 
similarly subject photoreceptors to oxidative stress which represents one of 
the most studied death stimulus to be counteracted in retinal degenerations 
[18]. 
When genetic mutations or external factors initiate one, or more, of those 
mechanisms, photoreceptors death processes are activated. Which kind of 
intracellular pathway is, exactly, responsible in leading photoreceptors to 
degenerate, is still unclear. However, apoptosis is the first death-process 
documented to be involved in RP mouse model [19]. There is still no doubt 
of apoptotic events in retinal degeneration, even if many studies report 
conflicting evidences and show that complex crosstalk and interconnected 
signals are involved. It is now accepted that apoptosis of photoreceptors 
can occur through both a caspase-dependent and independent via [20]. 
Many outcomes maintain that caspases participate in cone photoreceptor 
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apoptosis, although neither pharmacological inhibition nor genetic 
manipulation of caspase cascade are able to definitely rescue 
photoreceptors [21]. The involvement of other proteases linked to apoptotic 
cell death is investigated. In particular, calpains and caspases involvement 
in starved-661W cells is studied, showing that calpain-mediated pathway is 
independent and parallel with respect to caspase activation [22]. As 
upstream regulators of survival or apoptosis cascade, Bcl-2 family 
members too are taken into consideration and become the centre of an 
intriguing issue. On one hand, several studies highlight the importance of 
Bcl-2 as anti-apoptotic molecule [23] especially, supporting it by successful 
Bcl-2 overexpression in rescue 661W cells from death [24]. On the other 
hand, some evidences show Bcl-2 failure in promote salvage signaling [25]. 
In any case, an increased body of evidence suggests that apoptotic 
mitochondrial pathway is involved in caspase-dependent or independent 
apoptosis of retinal cells [26]. At the same time, in a model of retinal 
detachment, it is showed that apoptosis of photoreceptors can occur 
through both exstrinsic-Fas receptor mediated and intrinsic-mitochondrial 
cytochrome-c dependent activation [27]. All this studies on photoreceptors 
apoptosis prove the involvement of a variety of woven, parallel and 
sometimes contradictory pathways and draw attention, as well, to non-
apoptotic mechanisms [28], in particular, pointing up autophagy or its co-
occurrence with apoptosis [29]. Within all the mediators able to determine 
photoreceptors loss or survival through regulation of the abovementioned 
death-salvage processes, a family of bioactive molecules, sphingolipids 
(SPLs), is evidenced [30]. In particular, Ceramide (Cer), Sphingosine (Sph) 
and Sphingosine-1-phosphate (S1P), that play an active role in regulating 
cell death, survival and differentiation.  
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1.1.3.3 Therapeutic approaches in RP 
To preserve photoreceptors by RP-induced degeneration, many therapeutic 
strategies have been developed across the years, defining also a 
systematic classification depending on the degeneration stage (Fig. 1.3) 
[31]. 
 
Fig. 1.3: Schematic representation of therapeutic approaches on the basis of 
photoreceptor degeneration stage. Original source: Trifunović et al 2012. 
Ideally, the best way to fight a genetic disease is to correct the causative 
gene defect. Unfortunately this is not always feasible in RP due to, at least, 
two main causes: first of all, it should require an early disease diagnosis, 
allowing to act on genetic mutation in live cells, instead RP is recognized in 
patients with secondary cone degeneration already started and with all rod 
photoreceptors almost dead; secondly, a high efficiency to identify the gene 
of interest has a crucial importance and it is not easy to obtain given the 
wide heterogeneity of RP mutations. Nervertheless, experimental 
approaches to gene therapy in RP treatment have advanced in recent 
years. For instance, in arRP one of the most studied is the MERTK gene 
that encodes for the human receptor tyrosine kinase MER. MERTK located 
in the RPE mediates the association between these cells and the 
Introduction 
19 
 
photoreceptor outer segments. Regarding adRP, RHO and RDS/peripherin 
are the mutated proteins more studied. In both cases the interest is focused 
on a double gene therapy strategy consisting in siRNA-mediated 
suppression together with gene replacement [32]. 
Currently, many studies focus on mutation-independent ways in rescuing 
photoreceptors as, for example: retinal transplantation, retinal prostheses, 
retinal optogenetic therapy, electrical stimulation and neuroprotection 
through neurotrophic factors, pharmacological treatments and nutraceutical 
approaches. Replacement of degenerated photoreceptors with healthy 
transplanted tissue  or cells, is a well studied practice [33]. In the last years 
retinal prostheses has become more and more interesting, especially with 
the development of new biocompatible materials and nanotechnologies 
[34]. The most promising device designed in this moment is Alpha-IMS, a 
wireless subretinal implant made up of a 1500-pixel multiphotodiode array, 
which combines, better than others devices, clinical availability, vision 
restoration potential and long-term biocompatibility. Clinical trials for this 
intraocular photodiode implant have already demonstrated increased 
patient independence by mimicking natural vision under control of eye 
movement [35]. Retinal optogenetic strategy, in contrast to traditional gene 
therapy, employ light to control genetically targeted groups of cells. It acts 
from the inside of the cells, using light sensors to induce ganglion or bipolar 
cells to become reactive to light. Once activated from light, the sensors 
create an electrical current that can stimulate the cell [36]. For example, 
channelrhodopsin-2 (ChR2), a photosensitive cation-selective channel that 
contains an all-trans-retinal chromophores, is used in a mouse model of 
RP. When transduced on RGCs, it restores visual responses in mice [37]. 
Another potential therapeutic approach is low electrical stimulation of the 
eye that in theory releases neurotrophic substances. Recently, transcorneal 
electrical stimulation (TES) in RP patients has improved the function of 
retinal cells, as measured by electroretinography (ERG), and the visual field 
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[38]. Neuroprotection can be employed in two different direction: to 
straighten survival stimuli and/or to stop death induction. It can consist in a 
board variety of treatments: neurotrophic factors [39], as NGF, BDNF, 
CNTF, PEDF and GDNF; nutraceutical and antioxidant agents, as, for 
example, vitamin A and its derivates [40], docosahexaenoic acid (DHA) 
[41], lutein [42] and taurine [43]. 
1.1.4 661W: a cone-like cell line 
Many kinds of retinal cell lines are available for in vitro studies. Some of the 
most employed are: ARPE-19, human retinal pigment epithelium [44]; 
RGC-5, rat retinal ganglion cells [45]; R28, rat glial-neuronal cell line [46]. 
One in particular is suitable for the investigation of photoreceptors features 
and behaviours: 661W cell line. It is a cone-derived cell line, transformed by 
Dr. Muayyad Al-Ubaidi’s group (Department of Cell Biology, University of 
Oklahoma Health Science Centre, Oklahoma City, U.S.). 661W were 
cloned from retinal tumours of transgenic mouse line expressing the SV-40 
T antigen under control of the inter-photoreceptor retinal binding protein 
promoter (IRBP) [47]. Cells express cone but not rod specific antigens: 
SV40 T antigen, blue and green pigments, transducin, and cone arrestin. 
Immunocytochemical detection of blue and green opsins showed 
distribution throughout the cell, the nucleus included. However, these cells 
did not express rod-specific antigens, such as opsin and arrestin or rod- 
and cone-specific proteins such as phosducin, peripherin/RDS, and ROM1. 
Furthermore, the cells did not express RPE65, a cone and RPE specific 
protein [48]. 661W cell line is unique in its ability to respond to light 
stimulation and upon light stress it undergoes cell death, as showed for in 
vivo retina experiments (www.otd.ou.edu) [49]. Due to their easy handling 
and distinctive traits, 661W are widely used in ophthalmology research, 
especially as a model of photoreceptor degenerations subjecting them to 
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several kinds of stresses. In particular: light damage  [49, 50], serum 
deprivation [22] and oxidative stress by means of several compounds, for 
example: hydrogen peroxide [51] [29], sodium nitro-prusside [52], sodium 
iodate [53] and paraquat [54]. They are also employed to investigate retinal 
cells inter-relations [55-58], cellular toxicity of new treatments [59], [60], 
and, in general, to better understand death and salvage pathway of cone 
photoreceptors. 
1.1.4.1 Rescuing treatments on stressed 661W cells 
Since 661W cone-derived cell line has been recognized as a precious in 
vitro mean for studying photoreceptors, worldwide scientific works have 
incremented over years. In particular, the investigation on rescuing 
treatments represents one of the more examined field, ranging from 
electrical stimulation to a whole series of different antioxidant agents and 
nutraceutical compounds. Electrical stimulation (ES) has been shown to 
promote survival on light-damaged photoreceptor through diminished 
microglial activation and fortified Müller cells reactive gliosis, which may 
have great potential in ameliorating photoreceptor damage. ES might 
change the activation status of microglia and Müller cells by altering 
transmembrane voltage-gated ion channel activity suggesting that factors 
of microglia or Müller cells, that can be changed by electrical fields of 
different strengths, must be involved in this process [61]. DHA, that is the 
most polyunsaturated fatty acid present in retinal neurons [62], has been 
demonstrated to rescue 661W cells from oxidative stress, reducing calpain 
activation, cytochrome c release and caspase-3 action [63]. Unoprostone 
isopropyl (unoprostone) is a docosanoid, known to bear neuroprotective 
effects and to activate large conductance Ca2+-activated K+ (BK) channels. 
Unoprostone protects photoreceptors and RPE cells against oxidative- and 
light-induced damage by a mechanism different from antioxidant activity. In 
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particular, the protective effect of unoprostone is mediated by BK channel 
activation, probably on those existing in mitochondria, reducing the stress-
induced mitochondrial damage [64]. Purple rice bran extract (PRE), derived 
from  a coloured variety of Oryza sativa L. contains three anthocyanins 
(cyanidin 3-O-glucoside, peonidin 3-O-glucoside, and cyanidin 3-O-
gentiobioside) that are supposed to be its active components. PRE 
inhibition of reactive oxygen species (ROS) production in visible light 
irradiated-661W cells was demonstrated and proposed to occur by 
inhibition of p38 and/or JNK activation [50]. Carnosic acid (CA), present in 
rosemary extract, crosses the blood–brain barrier to exert neuroprotective 
effects. Recently, it was found to promote survival of 661W photoreceptors 
and ARPE-19 cells, against H2O2-induced cell death. Accounting for this 
effect, CA induced nuclear translocation of Nrf2 and then activated 
transcription of phase II genes [65]. Mandal’s group performs several 
studies on 661W evaluating the effects of antioxidant agents, especially 
through food-derived substances. Curcumin, a naturally occurring yellow 
pigment, isolated from the rhizomes of the plant Curcuma longa, was tested 
for its beneficial properties on 661W stressed with H2O2. Curcumin 
pretreated cells respond to oxidative stress activating cellular regulatory 
system such as NF-κB, Akt, Nrf2 and growth factors, which in turn inhibit 
cellular inflammatory responses and protect photoreceptors [66]. Caffeic 
acid phenethyl ester (CAPE), an active component of honeybee propolis, 
was found to activate the antioxidant gene expression pathway in H2O2-
challenged 661W cells and in rat retinas, enhancing ERG responses [51]. 
Interestingly, they evidences that CAPE-altered retinal fatty acid 
composition probably contributed to the higher ERG responses, confirming 
the involvement of lipids in optimal retinal function as previously 
demonstrated [67]. 
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1.2 Sphingolipids 
In 1884 J.L.W. Thudichum, a german-born physician and biochemist, wrote 
“A Treatise on the Chemical Constitution of Brain”. Here he described his 
studies on isolation and characterization of brain constituents and, for the 
first time, the backbone sphingolipid: sphingosine. He chose this name 
such as a parallelism of this enigmatic molecule and a mysterious 
mythological figure: the Sphinx. Across the years, many other sphingolipids 
have been described until a real family of bioactive molecules have been 
defined [68]. 
1.2.1 Structure  
Sphingolipids are a board and heterogeneous class of bioactive molecules, 
characterized by a common eighteen carbon amino-alcohol backbone, on 
which different biochemical modifications occur, giving rise to many 
metabolites. They are amphipathic molecules distinguished for relative 
hydrophilicity/hydrophobicity degree, strongly influencing individual 
intracellular localization and portability. In particular, hydrophilic region is 
represented by the sphingoid backbone, eventually linked to a charged 
headgroup, meanwhile lipidic portion is composed by N-linked acyl chains, 
with different numbers of carbons and insaturations. The simplest member, 
which actually corresponds to the common backbone, is Sph. It can 
undergo different modifications on C1 and C2 functional groups, in 
particular, acylation on C2-amino group that discriminates two big 
categories: sphingolipids with one or two hydrophobic chains. Different acyl 
chains are added through different ceramide synthases (CerS.s) that 
consequently generate respective Ceramides (Cer.s). Contemporarily, 
complexity degree can augment because of reactions on the C1-hydroxyl 
group. Sphingomylein (SM) arises from the binding of phosphocholine, 
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phosphorylation gives ceramide-1-phosphate (C1P), glycosylation, with  
glucose or galactose, creates the family of complex glycosphingolipids 
(GSLs). Finally, when acylation does not occur, phosphorylation on the 
hydroxyl group leads, for example, to S1P [69] (Fig. 1.4). 
 
 
Fig. 1.4: Structures of principal sphingolipids. 
Sphingolipids, as fundamental elements of lipid rafts, structurally constitute 
and functionally influence cellular membranes. Furthermore, they are 
intracellular messengers actively involved in cell functions regulation. Their 
heterogeneity is reflected also in their functions, insomuch as, relative 
species equilibrium is decisive in directing cell fate, towards death or 
survival pathways. The most representative example is the dualism 
between Cer, a death effector, and, in contrast, S1P that promotes cell 
proliferation and survival [68]. 
1.2.2 Sphingolipid metabolism 
Two major pathways collaborate in the synthesis of sphingolipids: de novo 
and salvage pathway. The first one starts and ends with non-sphingolipid 
molecules and is characterized by an enter point, serine palmitoyl 
transferase (SPT), which gives rise to the first sphingoid-based member of 
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the family, and an exit point, sphingosine-1-phosphate lyase (SPL) that 
allow the irreversible degradation of S1P. De novo synthesis, occurring in 
ER, begins with SPT catalysis of cytosolic serine and palmitoyl-CoA 
condensation, to give 3-ketodihydrosphingosine (3-KdhSph). Since it is 
reduced to dihydrosphingosine, (dhSph) by 3-ketosphinganine reductase 
(3-KSR), and acylated by (dihydro)ceramide synthases ((dh)CerSs) with 
various length acyl chains, to give a wide variety of (dihydro)ceramides 
((dh)Cer.s). By means of molecular oxygen and then NAPDH aid, 
dihydroceramide desaturase (DES) introduces a double bound in the C4-
C5 position of dhCer and generates Cer [69].   
Cer is now ready to eventually undergo different modifications: 
phosphorylation (ceramide kinase), glycosylation (glucosyl or galactosyl 
ceramide synthases) or condensation with a phosphocholine, deriving from 
phosphatidylcholine (PC), to generate SM (via sphingomyelin synthases). 
The latter two pools of sphingolipids represent the main source of Cer 
deriving from the salvage pathway, which implies its release from complex 
sphingolipids. Cer recycling synthesis takes place in the acidic subcellular 
compartments, the late endosomes and the lysosomes. Here specific 
exohydrolases and Acid sphingomyelinase (ASMase) degrade GSLs and 
SM to Cer that, in turn, is hydrolyzed by acid ceramidase (AC) to Sph able 
to exit the lysosomes. SM breakdown can occur also at the PM level by the 
action of Acid or neutral SMase depending on which side of the membrane 
the reaction happens and here again Cer is converted to Sph. At this point, 
all the Sph produced can explicate its intracellular functions or undergo to 
sphingosine kinases (SphK1-2) phosphorylation to generate S1P. In turn, 
S1P can act as second messenger, extracellular ligand or be metabolized. 
Two are the enzymes that can transform S1P, one is sphingosine-1-
phosphate phosphatases (SPP) that  regenerates Sph and the other one is 
sphingosine-1-phosphate lyase (SPL) that catalyzes the irreversible 
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degradation of S1P to phosphoethanolamine (PE, EA1P) and hexadecenal 
(Hex) (Fig. 1.5) [70]. 
 
Fig. 1.5 :Summarized pathways of sphingolipid metabolisms. Original source 
Mullen et al. 2012  
1.2.3 Subcellular compartmentalization 
Depending on their chemical nature, sphingolipids are free to move in 
cytoplasmatic and extracellular spaces or are relegated into biological 
membranes, and linked to specific mechanisms of transport to leave their 
site of generation. Precisely for this reason, the roles of many sphingolipids 
are tightly connected with specific subcellular localization of their synthesis 
enzymes. In particular, their mobility is based on the number of 
hydrophobic chains and on the charge at neutral PH. Cer, with two aliphatic 
chains and neutral headgroup, can flip-flop membranes but is unable to 
move in cytoplasm. It reaches the Golgi apparatus through two different 
ways depending on which metabolite is required: by the action of transfer 
protein CERT, if SM generation is needed or using vesicular transport if 
glucosylceramide (GluCer), or in general GSLs, must be synthesized. 
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Vesicular transport is also involved in the mobilization of Cer hydrophobic 
derivate species, SM and GSLs, to the PM, from where they can be 
addressed to lysosomes for entering the endosomal salvage pathway. Due 
to more hydrophilic nature, sphingolipids with just one aliphatic chain are 
soluble in cytosol and can freely move among intracellular membranes. 
Sph, which does not present any charge, is able to flip-flop membranes 
meanwhile, its phosphorylated metabolite, S1P, is linked to specific 
transporters to pass the lipid bilayer [68]. In particular, it is demonstrated 
that S1P traffic is linked to ATP binding cassette (ABC) members, on one 
hand ABCC1 that allows its exit [71] and on the other hand cystic fibrosis 
transmembrane regulator (CFTR), implicated in S1P influx [72].  
1.2.4 Ceramide 
Cer is one of the most studied sphingolipids and represents the central 
point of the entire family, it is the backbone of complex members and plays 
a strategic role in the membrane structure and in the activation of a wide 
variety of intracellular pathways, depending on cell type and extracellular 
stimulus. Cer synthesis is catalyzed by a family of ER-localized enzymes, 
CerS.s, that differ in their selectivity for acyl-CoAs based on the length of 
the acyl chain. CerS family is composed by six members (CerS1-6) that are 
differently expressed in tissues and differently react to stimuli, generating 
the particular Cer specie requested to face the incoming situation [73]. 
Cer involvement in many cellular process, such as growth arrest, 
differentiation, apoptosis and senescence makes the regulation of its 
synthesis and degradation an important target in several pathologies. 
Depending on the length of the fatty acid added to the sphingoid base, 
Cer.s can be constituted by 14 to 28 carbons chains, defining several 
different species involved in different kind of signaling [74]. Cer.s synthesis, 
that can occur both through de novo and salvage pathway, is induced in 
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response to stress stimuli such as cytokines (TNF, Fas, nerve growth 
factor), “environmental” stresses (heat, UV radiation, hypoxia/reperfusion) 
and chemotherapeutic agents [75]. The intracellular pathways activated by 
Cer are shown to be directly linked with the ceramide-activated protein 
phosphatases PP1 and PP2A [76], which is demonstrated to be involved in 
many Cer.s-induced effects, such as dephosphorylation/inactivation of anti-
apoptotic proteins including PKC, Akt and Bcl-2 [77] but also activation of 
apoptosis inducers as Bax [78]. Cer is also able to activate lysosomal 
protease cathepsin D [79], kinase suppressor of Ras as mediator of its 
effects on Ras, Raf, and ERKs [80] and the transcription factor NF-kB 
through PKC action [81]. 
1.2.5 Sphingosine-1-phospate 
Since its recognition as an active promoter of cellular growth and survival 
[82], S1P gains and keeps a central position in several investigations. 
Nowadays, it is known that this enigmatic sphingolipid has a pivotal role in 
many pathologies [83] such as cancer, atherosclerosis, inflammation, 
neurodegeneration, cardiovascular and respiratory affections [83]. It is also 
involved in tissue and organs development [84], in particular in 
cardiogenesis [85], limb development [86], neurogenesis [87] and 
angiogenesis [88]. S1P signaling pathways activation is a very intriguing 
issue, in particular, attention is drawn on identification and especially 
discrimination between its effect as second intracellular messenger and/or 
extracellular receptors ligand [89]. In order to clarify which way is involved 
in different S1P effects, many studies have been developed, in particular 
employng pertuxiss toxin as an inhibitor of S1P-specific G protein-coupled 
receptors (S1PR.s). As intracellular messenger, S1P plays critical roles in 
calcium regulation [90] and in apoptosis inhibition [91], in particular as anti-
apoptotic effector by means of many intracellular pathways. For instance, 
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intracellular-S1P is demonstrated to influence MAPK family members, 
which are known to modulate apoptosis both inducing its activation through 
JNK, inhibited by S1P, and, on the contrary, stopping the death process by 
ERK double effect on cytochrome c release. In fact, ERK is able to act 
upstream inactivating pro-apoptotic Bcl-2 family members and downstream 
inhibiting caspase cascade and its activation is improved by increased 
intracellular S1P levels [92]. SphK-S1P is also able to counteract apoptosis 
activating Akt, in hepatocytes [93]. Finally, it is demonstrated that 
intracellular synthesis of S1P is involved in NF-kB pathway activation, 
against TNFα effect [94]. 
On the other side, also S1P action through its surface receptors occupy a 
pivotal role in cell fate determination, similarly activating the same signaling 
pathways with respect to those depending on intracellular S1P. It is 
demonstrated that exogenous S1P can reduces Bax proteins levels in a 
lymphoblastoma cell line and antisense plasmids against its receptors 
counteract S1P-anti-apoptotic effect [95]. S1P activation of survival 
markers, such as ERK, are investigated in hepatoma cells stably 
expressing two of the five enzymes [96] and in endothelial cells where 
pertussis toxin blocks this ERK phosphorylation [97]. Furthermore, in this 
latter cellular type antisense for the first receptor attenuates S1P inhibition 
on Cer-induced apoptosis [98]. 
1.2.5.1Sphingosine-1-phosphate kinases 
S1P complexity already starts in its synthesis enzyme, indeed the 
phosphorylation of Sph is catalyzed by SphK, which exists in two isoforms, 
SphK-1 and SphK-2 [99] [100]. It is well known that SphK-1 is involved in 
cell growth induction and apoptosis inhibition [101]. SphK-1 resides in 
cytoplasm and, after ERK phosphorylation, translocates to the PM [102], 
where its substrate, PM-associated sphingosine, is located. Generated S1P 
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can activate intracellular signaling or, due to the PM proximity, easily exits 
the cell and interacts with its cell surface receptors. SphK-2 also needs to 
be activated by ERK phosphorylation [103] but, saved this trait, it deeply 
differs from its close relative in localization, function and influence on Cer 
contents. Primarily, SphK-2 is found at the level of internal membranes, in 
particular at ER, mitochondria and nucleus and surprisingly it promotes 
apoptosis [104]. Which mechanism is behind its action is still unclear but, 
rather than to its synthesized S1P receptor interaction, it is supposed to 
depend on an intrinsic characteristic of the enzyme aminoacidic sequence. 
It is demonstrated that SphK-2 contains a 9-amino acid sequence 
reminiscent of the Bcl-2 homology 3 (BH3) domain present in “BH3 domain-
only” proteins that, it is known to be responsible of their interaction with pro-
survival Bcl-2 family members and in consequent induction of apoptosis 
[105].  Despite that, it has recently been demonstrated that 
pharmacological inhibition of SphK-2 augments cancer cells sensitivity to 
apoptosis [106] and its knockout abolishes preconditioning-induced 
tolerance in ischemia/reperfusion injury [107]. Another important difference 
between these two enzymes is the influence on apoptotic Cer.s intracellular 
amounts: SphK-1 induces a decrease of Cer.s, meanwhile SphK-2 
promotes their synthesis [99]. 
All these outcomes open and keep alive an intriguing issue on the 
correlation between S1P functions and the enzyme isoform that catalyzes 
sphingosine phosphorylation, hence its site of creation. 
1.2.5.2 Sphingosine-1-phosphate receptors 
S1P-related cellular effects were associated to its function as intracellular 
second messenger until the discover of pertussis toxin ability in inhibiting 
some of its effect in fibroblasts [108]. Since then the outcome of S1P 
extracellular effects, mediated by surface receptors (S1PRs), were 
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investigated and deepened over years. In 1998, S1P was identified as a 
ligand of endothelial differentiation gene 1 (EDG1) product, a GPCR [109] 
and today the family has expanded with other four members (S1P1-5/EDG) 
that are accepted to be activated by extracellular S1P [110]. S1PRs add a 
further degree of complexity to the signaling pathways of this enigmatic 
sphingolipid for, at least, two reasons: their coupling to different kind of G 
proteins, activating respective pathways (Fig. 1.6), and their differential 
tissue and cell lineages expression, that can change depending on the 
stimulus received and/or the developmental stage. Furthermore, it is 
demonstrated, especially through investigation on S1P1, that S1PRs can 
be induced to internalize after acute agonist exposure. Two pathways of 
internalization are evidenced, the physiological agonist pathway which sees 
S1P-induced temporary internalization followed by intact receptor recycled 
to the PM where signaling can restart and superphysiological agonist 
pathway, linked to S1P-receptors potent ligands such as FTY720-P, in 
which ubiquitin pathway is activated and internalized receptors  degrade in 
lysosomes [111].  
S1P1/EDG1, the first discovered and the most well-studied of the family, is 
widely expressed in tissues and involved in T- and B- lymphocyte egress 
from lymphoid organs [112] also in inflammation [113] and tumorigenesis 
[114]. Like S1P1, S1P2/EDG5 shows a widespread expression. It is 
involved in increasing vascular permeability, through disruption of adherens 
junctions between endothelial cells [115] and upregulated by hypoxia in the 
retina inducing defective neovascularization and inflammatory response 
increasing cyclo-oxygenase-2 [116]. S1P2 plays pivotal role also in 
development, immunity, neural functions and cancer [117]. S1P3/EDG3, 
due to its coordination with S1P1 and S1P2, is barely studied alone. It is 
shown to play a role in immune reactions [118], in multiple sclerosis [119] 
and inflammation [120]. S1P4/EDG6 is highly expressed in lymphocytic and 
hematopoietic cells even if its role in immune modulation is still unclear 
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[121]. The last receptor and less investigated of the family is S15/EDG8. It 
shows some traits of difference against the others receptors. It is especially 
studied in brain and of particular interest is its differential activation in 
oligodendrocytes depending on their developmental stage. In fact, it 
mediates process retraction and impedes migration of immature cells 
whereas regulates survival of mature ones through Akt activation [122]. It is 
also involved in maintenance of the human brain endothelial barrier, in 
inhibiting inflammation by NF-kB activation [123] and in cancer [124]. 
 
 
Fig. 1.6: Schematic representation of different S1PRs G-protein depending 
pathways. Original source: www.caymanchem.com 
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1.2.6 The entrance and the exit of the pathway: SPT and SPL  
As descrived above, de novo sphingolipid synthesis starts and ends with 
no-sphingoid molecules and the two reactions, that respectively initiate the 
biosynthesis and terminate the catabolism of Cer, are catalyzed by two 
essential pyridoxal 5’-phosphate (PLP)-dependent enzymes: SPT and SPL 
(Fig. 1.7). They share a similar mechanism of action, which initiates with 
the replacement of lysine (K265 in SPT and K311 in SPL), in the Schiff 
base formed with the aldehyde group of PLP, with serine or S1P. The 
resulting external aldimine undergo to different modifications; in particular, 
in SPT it is subjected to a nucleophilic attack on Cα by palmitoyl-CoA 
thioester and, after the formation of two quinonoid intermediates and other 
two external aldimines, it becomes 3-KdhSph, causing the internal aldimine 
restoration. On the other hand, in SPL the external aldimine gives Hex after 
a retro-aldol cleavage, forms a quinonoid intermediate, another external 
aldimine and finally release PE to allow the re-formation of the resting state 
internal aldimine [125]. 
SPT is the first enzyme of the biosynthesis, localized in ER membrane-
associated complex. It is composed by 3 subunits: LCB1, LCB2 and LCB3. 
The last one is recently characterized [126] and recognized as an isoform 
of LCB2. The latter two, due to their PLP-binding, are recognized as 
catalytic subunits, instead LCB1 relation with PLP is still to be clarified 
[127]. SPT expression is modulated by different stimuli [128] such as 
endotoxins or cytokines [129] and UVB irradiation [130]. 
SPL is a homo-oligomer, situated at the ER membrane with the active site 
exposed to the cytosol. Its activity is tightly controlled at different levels 
such as transcriptional, epigenetic and post-translational [131]. Due to its 
function as sphingolipid pathway gatekeeper and S1P level regulator it is 
considered an important target for several therapeutic strategies. At the 
moment, it is especially studied in autoimmune diseases, due to its role in 
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modulating lymphocytes trafficking; in fact it is widely demonstrated that 
SPL inhibition causes lymphopenia linked to S1P-gradient modification 
[132]. Furthermore, SPL expression regulation is suggested to be involved 
in inflammation, cancer [133], metastatic tumours [134] and protective 
effect against cytotoxic therapy and radiation [135]. 
 
 
Fig. 1.7: X-ray structure of SpSPT (Sphingomonas paucimobilis) and StSPL 
(Symbiobacterium thermophilum). Dimeric structure of SpSPT and StSPL, 
represented in cartoon and ribbon with N- and C- termini indicated. PLP appears in 
ball-and-stick in the same color of the corresponding subunit. Original source: 
Bourquin et al. 2011 
1.2.6.1 Sphingolipids pathway inhibitors: Myriocin and THI 
Modification of sphingolipids levels, especially through the manipulation of 
critical enzymes of their biosynthetic pathway, is the basis for the study of 
increasing number of diseases, leading to the development of many 
enzymatic inhibitors or activators.  
In the case of SPT, Myriocin represents a specific tool to powerfully inhibit 
de novo synthesis. Myriocin is a natural product that was firstly isolated for 
its antibiotic and antifungal activity from Myriococcum albomyces [136] and 
Mycelia sterilia (Thermozymocidin) [137], and some years later also from 
Isaria sinclairi (ISP-I) [138]. In 1995, its in vitro inhibition of cell growth was 
demonstrated to derive by SPT activity inhibition [139]. Across the years, 
Myriocin has been employed in a huge number of researches on: cancer 
Introduction 
35 
 
[140] [141, 142], RP [143], multiple sclerosis [144], obesity [145] 
atherosclerosis and cardiomyopathies [146]. Recently, its mechanism of 
action has been clarified: it is defined to act as a “suicide inhibitor”. Myriocin 
reacts with PLP to form an external aldimine that decomposes after 16 
hours producing a long chain aldehyde, able to bind the active site lysine 
and irreversibly inactivate the enzyme [147]. 
SPL can be inhibited by different compounds: among these, there is 2-
Acetyl-5-tetrahydroxybutyl imidazole, THI [148-150]. THI derives from 
ammonia caramel colour III, a food colorant belonging to the big family of 
ammonia caramel colours (AC) and is employed in beers, sauces and 
biscuits. THI biological effects were firstly evidenced in 1988, in rats, 
defining it as a negative modulator of circulating lymphocytes. Interestingly 
it was observed that deficiency of pyridoxine (Vitamin B6, whom PLP is the 
active form) in the diet was shown to augment THI-induced  lymphopenia 
[151]. The same year another group analyzed THI effect on mouse and 
observed that THI is able to selectively induce lymphopenia also in this 
animal model [152]. In the following years, many studies focused on THI 
toxicity and on the importance of vitamin B6 in counteracting THI effect, 
until 1992 when a human trial, on individuals with a marginal deficit in 
vitamin B6, demonstrated that THI, as others ACs, did not induce any effect 
on blood and lympha parameters [153]. In 2005, for the first time, THI 
action was associated to the inhibition of SPL. Schwab’s group 
demonstrated that S1P abundance in lymphoid tissues of mice increased 
more than 100-fold after THI treatment and that it depended on SPL 
inhibition, especially given to the ability of vitamin B6 to tightly influence THI 
and other SPL inhibitors activity [154] [155]. Recently, it has been 
demonstrated that it has a cardioprotective effect on ischemia/reperfusion 
injury on murine heart [156], it abrogates eosinophilic inflammation in a 
mouse model of allergic rhinitis [157] and it is involved in the maintenance 
of energy metabolism in dystrophic mouse [158].  
Introduction 
36 
 
1.2.7 Sphingolipids in the eye  
The first direct evidence of a correlation between sphingolipids and 
photoreceptors degeneration arrived in 2003 from Acharya’s group [159]. 
By lowering Cer levels, they succeeded in rescueing photoreceptors in a 
Drosophila model of retinal degeneration. This outcome linked two 
important fields of research giving rise to many further, in vitro and in vivo, 
investigations. Some years later, on rat retinal neuronal cultures, C2-Cer 
treatment triggered photoreceptor apoptosis, meanwhile Cer synthesis 
inhibition counteracted oxidative stress-induced death [160]. Similarly on 
661W cells, oxidative stress, produced with sodium nitroprusside, 
stimulated Cer accumulation that is reduced through a SMase inhibitor 
[161]. Furthermore, sphingolipids result crucial also for their role as 
membrane structural component, in fact membrane domains enriched of 
sphingolipids are associated with critical photoreceptor membrane 
channels and manipulation of the sphingolipid pathway promotes their 
delocalization and dysfunction [162]. Interestingly, in a  mouse model of 
RP, rd10, the inhibition of Cer synthesis slows retinal degeneration and 
preserves photoreceptors structure and function [143]. Regarding human 
retinal degeneration, the connection with sphingolipids was demonstrated 
with the finding of a mutation in a Cer kinase-like protein and arRP [17]. On 
the other side, S1P effects were studied in both rescue of degenerating 
photoreceptors and developmental retina. Apoptosis of rat retinal neuronal 
cells was induced by means of oxidative stress and counteracted by S1P 
addiction [30]. Moreover, GDNF is demonstrated to induce Sphk1 
expression and translocation to the PM and, in addition, its positive effect 
on photoreceptors is blocked by S1P inhibition. Finally, S1P is able to 
increase proliferation of photoreceptor progenitors and then stimulates their 
differentiation [163].
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Due to their complexity, photoreceptors are the most fragile cells among 
those composing the retina especially due to their continuous exposition to 
light, high rate energy demand and constant outer segment turnover [164]. 
Their degeneration is the critical step of many severe retinal pathologies 
[18], such as RP [8]. Nevertheless, most of RP genetic mutations are 
related to rods, that indeed degenerates in the first stage of the disease, 
the following secondary cone degeneration is all along considered the 
major target in RP prevention [165], as also declared by Wright, in 1997: 
“Keep the cones alive and some 1,5 million people worldwide will see...” 
[166]. In fact, while rods death leads to night blindness, allowing an almost 
normal life, cones loss prevents diurnal vision and represents a tragic 
invalidating consequence of the pathology. 
Given the critical role of sphingolipids in retinal degeneration [30] and 
recent evidences that Cer metabolism modulation can recover 
photoreceptors [143], particularly cones [167], in a murine model of RP, we 
investigated if both prevention of Cer formation by treating cells with 
Myriocin and most of all increasing the endogenous level of the pro-survival 
S1P, by inhibition of its degradation, can promote cones resistance to 
stress and save their functionality.  
In order to demonstrate our hypothesis, we employed an in vitro model of 
cone-like cells and mimicked retinal degeneration stress by treating them 
with oxidative agents or depriving them of growth factors, the two 
conditions affecting cones upon rods death in RP retina.  
We intend to demonstrate that not only impairment of Cer formation delays 
cones death but also the increase of endogenous S1P triggers a survival 
response that is aimed at overcoming oxidative stress. If our hypothesis is 
confirmed, combination of sphingolipid metabolism inhibitor can be 
envisaged as powerful therapy against RP retinal degeneration. 
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This study aims at demonstrating the involvement of sphingolipids in 
photoreceptor degeneration, focusing on: 
1) Endogenous accumulation and signaling of S1P as a mean to rescue 
photoreceptors from stress induced death. 
2)  Combination of S1P intracellular increase and Cer de novo synthesis 
inhibition to obtain additive effect on photoreceptor survival upon 
stress. 
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4.1 Reagents and antibodies 
H2O2 (hydrogen peroxide), THI (2-acetyl-4(5)-(1(R),2(S),3(R),4-
tetrahydroxybutyl)-imidazole), Myriocin, fatty acid free Bovine Serum 
Albumin, bovine serum albumin (BSA), MTT dye, Trypan blue dye, 
protease inhibitor cocktail, leupeptin, Pyridoxal-5'-phosphate, L-Serine, 
Palmitoyl coenzyme A and Hoechst 33258 dye were purchased from 
Sigma-Aldrich (St. Louis, Missouri USA). Sphingosine-1-phosphate (S1P) 
was purcheased from Avanti Polar Lipids. Penicillin and streptomycin 
(Invitrogen) were purchased from Life Technologies Italia (Monza, Italy). 
DMEM culture media, fetal bovine serum (FBS) and the 
chemoluminescence system LiteAbLot were purchased from EuroClone 
Life Science Division (Milan, Italy). SYBR Premix Ex Taq (Tli RNaseH Plus) 
was purcheased from Takara Bio, Inc. (Japan), RT-qPCR primers from 
Eurofins Genomics (Gerrmany) and  L-[3H(G)]-Serine from PerkinElmer, 
Inc. (Massachusetts, USA) 
Primary antibodies were purcheased from: p-Akt (#9271) and t-Akt (#9272) 
Cell Signaling; p-ERK1/2 (sc-7383), t-ERK1/2 (sc-93), Bcl-2 (sc-7382), Bax 
(sc-7480) and Nrf2 (sc-722) Santa Cruz; β-actin (A5316) Sigma. 
Horseradish peroxidase (HRP)-conjugated secondary antibody were from 
Jackson Laboratories (Bar Harbor, Maine, USA). 
4.2 Cell cultures 
4.2.1 661W 
Cone-derived cell line, 661W cells, were provided by Dr. Muayyad Al-
Ubaidi (Department of Cell Biology, University of Oklahoma Health Science 
Center, Oklahoma City, U.S.). 661W were cloned from retinal tumours of 
transgenic mouse line expressing the SV-40 T antigen under control of the 
inter-photoreceptor retinal binding protein promoter (IRBP) [47]. 661W 
Material and Methods 
43 
 
growth doubling time is of ~24 hours in Dulbecco’s modified Eagle’s 
medium (DMEM), supplemented with 10% fetal bovine serum (FBS) and 
1% penicillin/streptomycin solution as antibiotics. They were maintained in 
a sterile and controlled atmosphere incubator at 5% CO2, 95% humidity at 
37 °C. Experiments were performed in 96 (3x103 cells in 0,2 ml), 6 (2,5x105 
cells in 3 ml) multiwell plates and 100 mm Petri dishes (8x105 cells in 6 ml) 
starting treatments after about 24 hours, however when cells reached a 
60%-70% confluence. 
4.2.2 MDA-MB-231 
Human breast cancer cell line MDA-MB-231, from America Type Culture 
Collection (ATCC), Rockville, MD, USA, was chosen as source of Serine-
Palmitoyl Transferase (SPT) enzyme. Cells were maintained at 5% CO2, 
95% humidity at 37 °C in DMEM, supplemented with 10% FBS and 1% 
penicillin/streptomycin solution as antibiotics. Cells were seeded in 150mm 
Petri dishes (3x106 cells in 24 ml) and left to grow for at least 3 days, 
however until 80-90% confluence was reached, before collected them for 
microsomal membranes fraction extraction, due to the localization of the 
studied enzyme at this level. 
4.3 Cells treatments 
661W cells were stressed through hydrogen peroxide (H2O2 1mM) and 
serum starvation (1% FBS DMEM). They were pre or cotreated with the 
following compound: S1P (1µM and 100nM), solubilized in a 
methanol:water (95:5) solution, dried through a stream of dry nitrogen and 
stored according to the Avanti Polar Lipids protocol. Before use, S1P was 
resuspended in sterile fatty acid free Bovine Serum Albumin (BSA, 4 
mg/ml), to make a 125 µM S1P solution and incubated for 30 minutes at 
37°C, sonicated and vortexed occasionally. THI (75 µM) and Myriocin (10 
µM) were both solved in dimethyl sulfoxide (DMSO). 
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The same procedure was followed prior to all assays: cells were seeded 
and left to grown for about 24 hours in 10% FBS/1% penicillin/streptomycin 
DMEM. Before treatments, the media was replaced with 10% or 1% FBS 
DMEM, depending on the kind of stress, always without antibiotics, and 
appropriate compound was added. At proper time point, they were 
collected and processed according to different assays. 
4.4 3-(4,5-dimetiltiazol-2-il)-2,5difeniltetrazolio bromide (MTT) assay 
Cell growth curve was performed, evaluating cell proliferation by MTT 
assay at 12, 24 and 48 hours after stress. Cells were seeded in 96-well 
tissue culture plates at 3x104 cells/well. At every  time point,  20 µl of MTT 
solution (5 mg/ml) were added in each well and 661W cells were incubated, 
in darkness, at 37°C for 4 h. Media was removed, 100 µl of DMSO was 
added and the optical density (O.D.) was measured at 540 nm with a 
microplate reader (Sunrise Tecan microplate reader). Identical 
concentrations were tested in six-repetitions and the assay performed at 
least three times. Results are expressed as proliferation index fold change 
with respect to time zero (T0), against time. 
4.5 Trypan blue dye exclusion test 
Trypan blue assay was used to evaluate the number of viable cells after 
treatments. 661W cells were seeded in tissue culture Petri dishes (100mm) 
at 8x105 cells/Petri, treated and after 12 hours, counting was evaluated in 
experimental and control groups. For that, cells were detached using 0.25% 
trypsin, for 5 minutes at 37°C, collected and resuspended in 2 ml of 
Phosphate buffered saline (PBS) solution, 90 µl aliquots of this cell 
suspension were added to 10 µl of 0,4% Trypan blue dye (1:10). Next, live 
and dead cells were counted using Bürker chamber under a MoticAE31 
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optical inverted microscope. Live and dead cells were reported as both 
number of cells and percentages over the control. 
4.6 Western blotting 
Protein expression levels were analyzed by Western blotting. Cells, seeded 
at 8x105 in each tissue culture Petri dishes (100 mm), were treated and, 
after 12 hours, collected by scraping on ice in cold PBS-EDTA buffer, 
containing protease inhibitor cocktail. Then samples were centrifuged at 
800g for 5 minutes at 4 °C, supernatants were discarded and pellets 
resuspended in 80 ul of the same buffer. A 15 ul aliquot, for every sample, 
was used for total protein quantification (µg/ul), through Bradford method 
[168]. The remaining suspension was added with Laemmli solution [169], 
boiled for 8 min and stored at -20°C. Proteins (15ug) were separated by 
SDS-PAGE with different concentrations acrylamide gels, depending on 
investigated protein size (10% for ERKs, Akt and Nrf2, 15% for Bcl2 and 
Bax. Proteins were transferred onto a nitrocellulose membrane with and 
unspecific binding sites were blocked by one hour of 5% dry skimmed milk 
in tris-buffered saline (TBS) containing 0.1% Tween-20 (TBS-T) For 
immunoblotting, membranes were incubated at 4°C overnight with primary 
antibodies: anti p-ERK1/2 (1:500 in TBS-T-3% BSA), anti t-ERK1/2 (1:500 
in TBS-T-3% BSA), anti p-Akt (1:1000 in TBS-T-3% BSA), anti t-Akt 
(1:1000 in TBS-T-3% BSA), anti Bcl-2 (1:200 in TBS-T), anti Bax (1:200 in 
TBS-T) and anti Nrf2 (1:1000 in TBS-T). β-actin levels (anti β-actin 1:2000 
in TBS-T-3% BSA) were quantified for Nrf2 amounts normalization and as 
loading control for all others markers analyzed as protein levels ratio: 
ERK1/2 and Akt (phosphorylated on total form), Bcl-2 and Bax (Bcl-2, anti-
apoptotic, on Bax, pro-apoptotic, marker). Membranes were incubated with 
the proper horseradish peroxidise (HRP) conjugated secondary antibody 
diluted 1:10000 in TBS-T-5% dry skimmed milk or TBS-T, depending on the 
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primary antibody. Bands detection was obtained by chemoluminescence 
and X-ray film exposure. Specific bands intensity was quantified by Gel Doc 
2000, with Quantity one software (Bio-rad gel doc system, Chemidoc XRS). 
Levels of proteins were expressed in different ways, see respective figure 
captains for clarifications. 
4.7 Liquid chromatography-tandem mass spectrometry (LC–MS) 
analysis  
In order to measure sphingolipids intracellular amounts, cells were 
collected and total protein fractions were quantified following the protocol 
applied for Western blotting analyses. The obtained cellular pellets  were 
lyophilized or directly frozen at -80 °C. Sphingolipids extracts from 
untreated and treated cells, fortified with internal standards (N-
dodecanoylsphingosine, N-dodecanoylglucosylsphingosine, N-
dodecanoylsphingosyl phosphorylcholine, C17-sphinganine (0.2 nmol 
each) and C17-sphinganine-1-phosphate (0,1 nmol), were prepared and 
analyzed as reported [170]. S1P amount was measured without adding 
internal standards. 
4.8 Terminal deoxynucleotidyl transferase dUTP nick end labelling 
(TUNEL) assay 
Apoptosis degree was evaluated by means of TUNEL test, trypsinized cells 
were washed in 1 ml cold PBS and centrifuged 5 min at 1000 rpm at 4° C. 
The pellet was resuspended in 500 µl of 4% cold buffered formalin for 30 
min, washed in PBS, centrifuged (1000 rpm, 5 minutes, 4 °C), resuspended 
in 50 µl PBS and stratified on slides (Superfrost Plus-Menzel Gmbh and 
CoKG, Braunschweg, Germany). After drying at room temperature, slides 
were maintained at –20 °C until use. Apoptosis was determined by the TdT 
assay (In situ Cell Death Detection Kit, TMR Roche Diagnostics, 
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Mannheim, Germany) in an inverted fluorescence microscope (40x 
magnification) Axiovert25 CFL (Zeiss, Göttingen, Germany) equipped for 
the detection of rhodamine (filter set 15, excitation band pass 546 nm, 
emission low-pass 590 nm). Nuclei were stained with the karyophilic dye 
Hoechst 33258 (250 ng/ul) for 3 minutes at room temperature in the dark, 
followed by rinsing twice in PBS and coverslipping. Slides were examined 
using a filter for Hoechst staining (filter set 02, excitation band pass 365 
nm, emission low-pass 420 nm). Images were acquired by a digital camera 
(DS-2MV; Nikon, Tokyo, Japan) and the number of TdT-labeled nuclei 
counted (8-10 random fields in a blinded procedure). Results are expressed 
as number of TdT-labeled nuclei/total nuclei. 
4.9 Ferric reducing antioxidant power (FRAP) assay 
Cellular supernatants were separated from pellets and used to perform 
FRAP assay according to the method of Benzie & Strain [171] with minor 
modifications. Briefly, to prepare the FRAP solution, 100 ml of acetate 
buffer 300 mM, adjusted to PH 3.6 with acetic acid, were mixed with 10 ml 
of ferric chloride hexahydrate 20 mM dissolved in distilled water and 10 ml 
of 2,4,6-tris(2-pyridyl)-s-triazine 10 mM dissolved in HCl 40 mM. 100 µl of 
sample were added to 3 ml of a freshly prepared FRAP solution in glass 
test tubes in triplicate and the absorbance was measured at 593 nm after 5 
minutes of incubation at 37 °C against a blank of acetate buffer. Aqueous 
solutions of FeSO4·7H2O (100–1000 µM) were used for the calibration and 
the results were expressed as FRAP value (µM Fe (II)) of the samples 
[172]. 
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4.10 Real-time PCR (RT-qPCR) 
To evaluate the influence of treatments on mRNA synthesis, real-time PCR 
was performed. 661W cells were seeded in 6-well tissue culture plates at 
2,5x105 cells/well and treated. After 12 hours, total RNA was extracted with 
miRNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. 
RNA was quantified by fluorometry with Qubit (Life Technologies Italia) and 
about 1 ug of total RNA was reverse transcribed in cDNA. The reaction was 
performed in a final volume of 20 µl starting with an incubation of 45 
minutes at 37 °C and continuing for others 45 minutes at 42 °C to induce 
the degradation of eventual secondary RNA structures. RT-q Polymerase 
chain reaction amplification of the respective genes were performed with 
the SYBR Premix Ex Taq and set up in a total volume of 20 µl, with 200nM 
forward and reverse primers through the SYBR Green system according to 
the protocol. For the amplification, the following primers were used (5′-
>3′orientation). Primer’s sequences of target genes, heme oxygenase-1 
(HO-1) [51] and S1PRs (S1P1, S1P2, S1P3, S1P4 and S1P5) [173], were 
obtained from published studies.  
HO-1  forward TCTATCGTGCTCGCATGAAC 
  reverse CTGTCTGTGAGGGACTCTGG 
S1P1  forward AAATGCCCCAACGGAGACTCTG 
  reverse TTGCTGCGGCTAAATTCCATGC 
S1P2  forward CCCAACTCCGGGACATAGA 
  reverse ACAGCCAGTGGTTGGTTTTG 
S1P3  forward TCAGTGGTTCATCATGCTGG 
  reverse CAGGTCTTCCTTGACCTTCG 
S1P4  forward AAGACCAGCCGTGTGTATGG 
  reverse TCAGCACGGTGTTGAGTAGC 
S1P5  forward GCCTGGTGCCTACTGCTACAG 
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  reverse CCTCCGTCGCTGGCTATTTCC 
GAPDH forward AACTTTGGCATTGTGGAAGG 
  reverse ACACATTGGGGGTAGGAACA 
 
Specificity of PCR products was confirmed by analysis of a melting curve. 
Real-time PCR amplifications were performed on a CFX96 Real-Time 
System (Bio-Rad). Amplification of the house-keeping gene GAPDH 
(Glyceraldehyde 3-phosphate dehydrogenase) was performed to 
standardize the amount of sample RNA. Relative quantification of gene 
expression was achieved using the 2-DeltaDeltaCt method as previously 
described [174]. 
4.11 Serine palmitoyltransferase (SPT) activity assay 
Microsomal membranes fraction was collected through MDA-MB-231 
homogenization in a specific extraction buffer (Hepes PH 7.4 25 mM, EGTA 
PH 7.8 5 mM, NaF 50 mM, leupeptin 10 µg/ml and tripsin inhibitor 10 µg/ml) 
and centrifugation at 4070 rpm for 10 minutes at 4 °C. After Bradford 
protein assay, the enzymatic assay was performed incubating 300 µg of 
total proteins at 37 °C for 30 minutes in the reacting buffer (Hepes PH 8.3 
100 mM, EDTA PH 7.4 2.5 mM and DTT 5 mM) containing Pyridoxal-5'-
phosphate 50 µM as enzymatic cofactor and L-[3H(G)]-Serine (1 mM, 2 µCi 
specific activity 26 Ci/mmol), L-Serine (1 mM) and Palmitoyl coenzyme A 
(200 µM) as substrates. Counts per minute (CPM) were measured with β-
counter (Packard Tri-Carb Liquid Scintillation Analyzer, model 2900TR) 
after washing three times the organic phase with bi-distilled water, dividing 
the two phases (hydrophilic and organic) with various centrifugations, 
drying up the samples overnight at 39 °C and resuspending them in 
scintillation cocktail. Results are expressed as percentage of enzymatic 
activity with respect to the control (DMSO) ± Standard Deviation, assuming 
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boiled enzyme as zero. Only for most interesting compounds, IC50 was 
obtained through a concentration-response curve performed calculating the 
enzymatic activity ± Standard Deviation at different concentrations. 
4.12 Statistical analysis 
Data on 661W cells are provided as means ± SEM. Statistic significance 
was evaluated for all data, choosing the best method depending on the 
number of analyzed groups: paired two-tailed Student’s t-test for two-group 
comparison and one-way analysis of variance (ANOVA) for multiple-group 
comparison, with Bonferroni post hoc test when P<0.05. Only results with 
P<0.05 were considered statistically significant. All statistical computations 
were carried out with InStat 3.01 (GraphPad Software, San Diego, 
California, USA). Western blot and TUNEL images are the most 
representative of at least three independent experiments. 
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5.1 H2O2 and serum deprivation inhibit proliferation and viability in 
cone photoreceptors 
661W cells were challenged through 1mM H2O2 or starved in 1% serum 
medium (serum deprivation, SD) for 12, 24 and 48 hours and cellular 
proliferation was assessed by MTT assay. Oxidative stress induced 30% 
inhibition of cellular proliferation within the first 12 hours of treatment, 
whereas SD induced 50% proliferation inhibition in 48 hours (Fig. 5.1A and 
B). Both treatments induced a three folds increase of cell death, measured 
by Trypan blue assay, after 12 hours (Fig. 5.1C). 
 
Fig. 5.1: Oxidative stress and serum deprivation affect in vitro cone 
photoreceptors proliferation and viability. Cells were treated with 1mM H2O2 or 
starved with 1% FBS DMEM for 12, 24 and 48 hours. A-B) Cell proliferation was 
evaluated by MTT assay. Data are expressed as fold change vs time zero (T0) 
against time. C) Photoreceptors viability was assessed through Trypan blue 
exclusion assay after 12 hours of stresses. The number of live and dead cells was 
showed in graphs. Data are obtained from three experiments and values are 
expressed as average ± SEM. Significance was analyzed through ANOVA followed 
by Bonferroni multiple comparisons post test, when P<0.05. *P < 0.05, **P < 0.01, 
***P < 0.001, n.s. not significant. SD: Serum deprivation. 
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In order to identify the mechanism underpinning cell arrest and death, we 
studied the involvement of key mediators of survival/death signaling. Stress 
activated kinases ERK1 and 2 are known to be phosphorylated to promote 
survival. In H2O2 or SD 12 hours treated 661W cells, ERKs were 
significantly dephosphorylated, in agreement to the above reported effect 
on cell death induction (Fig. 5.2A). Akt phosphorylation on Ser 473, was 
shown to be enhanced under acute, but sub-lethal oxidative stress in retinal 
pigment epithelial cells [175]. 661W cells, treated with 1mM H2O2 or SD for 
12 hours exhibited an increase of Akt phosphorylation on Ser 473: six folds 
and four folds respectively for H2O2 and SD (Fig. 5.2B). 
 
Fig. 5.2: Oxidative stress and serum deprivation modulate ERK1/2 and Akt 
phosphorylation. Cells were treated with 1mM H2O2 or starved with 1% FBS 
DMEM for 12 hours. A-B) The effect of 12 hours of 1mM H2O2 or 1% SD treatment 
was studied on ERKs and Akt phosphorylation. Cell lysates were resolved by SDS-
PAGE and immunoblotted with antibodies for p-ERKs, t-ERKs (44 and 42 kDa), p-
Akt and t-Akt (60 kDa). Value of densitometry quantification of phosphorylated 
forms were normalized on corresponding total forms and the ratio was expressed 
as fold change vs control (Ctr), untreated cells; β-actin (43 kDa) was showed as 
loading control. Western blot images are the most significant among those 
quantified. Data are obtained from three experiments and values are expressed as 
average ± SEM. Significance was analyzed through ANOVA followed by Bonferroni 
multiple comparisons post test, when P<0.05. *P < 0.05, **P < 0.01, ***P < 0.001, 
n.s. not significant. SD: Serum deprivation. 
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5.2 THI rescues photoreceptors from both stresses, without affecting 
unchallenged cells. 
THI is an inhibitor of SPL, leading to S1P cell accumulation. S1P is a pro-
survival inducer which was shown to counteract Cer induced cell death 
when its intracellular levels raise above the baseline. In order to rescue 
photoreceptors from stress induced cell death, we treated 661W cells with 
75 µM THI, either 2 hours before H2O2-stimulus or in cotreatment with SD. 
We monitored cellular proliferation at 12, 24 and 48 hours, and observed a 
slight but significant recovery in THI cell survival, visible already at 12 hours 
and more evident over time (Fig. 5.3A and B). After 12 hours of treatments, 
we observed that the percentage of live cells augmented almost of 25% 
and the number of dead cells lowered almost three folds in both stresses 
(Fig. 5.3C and D). 
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Fig. 5.3: THI attenuates stresses effects on 661W cells. 75µM THI was added 
to cells, two hours before 1mM H2O2 and directly with 1% FBS DMEM (SD). Cells 
were analyzed after 12, 24 and 48 hours from stress induction. A-B) Cell 
proliferation was evaluated by MTT assay. Data are expressed as fold change vs 
time zero (T0), against time. C-D) Photoreceptors viability, in presence of THI, was 
assessed by Trypan blue exclusion assay after 12 hours of stress. Percentages of 
live and dead cells were calculated considering total cells as 100%. Data are 
obtained from three independent experiments and values are expressed as 
average ± SEM. Significance was analyzed through Student t-test. *P < 0.05, **P < 
0.01, ***P < 0.001, n.s. not significant. SD: Serum deprivation  
 
Once again, we investigated a possible involvement of ERKs and Akt 
pathways: THI always antagonized death-stimuli, by increasing activation of 
ERK by 1.5 folds against H2O2 and two folds against SD (Fig. 5.4A) and by 
inducing a 35-40% reduction of Ser473 Akt phosphorylation (Fig. 5.4B).  
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Fig. 5.4: THI counteracts stresses effect on ERK1/2 an Akt phosphorylation. 
75µM THI was added to cells, two hours before 1mM H2O2 and directly with 1% 
FBS DMEM. THI rescue action was studied on ERKs and Akt phosphorylation. A-
B) Cell lysates were resolved by SDS-PAGE and immunoblotted with antibodies for 
p-ERKs, t-ERKs (44 and 42 kDa), p-Akt and t-Akt (60 kDa). Value of densitometry 
quantification of phosphorylated forms were normalized on corresponding total 
forms and the ratio was expressed as fold change vs stress (H2O2 or SD); β-actin 
was showed as loading control. Western blot images are the most significant 
among those quantified. Data are obtained from three independent experiments 
and values are expressed as average ± SEM. Significance was analyzed through 
Student t-test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not significant. SD: Serum 
deprivation  
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We also evaluated THI influence on unstressed photoreceptor viability, 
showing that the enzymatic inhibitor did have no significant effects on 
survival per se (no change in live and dead cells ratio: Fig. 5.5). 
 
 
Fig. 5.5: THI does not influence photoreceptors viability. Percentages of live 
and dead cells were evaluated after 12 hours of 75µM THI, considering total cells 
as 100%. Data are obtained from three independent experiments and values are 
expressed as average ± SEM. Significance was analyzed through Student t-test, 
when P<0.05. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not significant. 
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5.3 H2O2 and SD influence Cer contents in different ways 
We investigated how stress influenced Cer total and single species amount, 
differing for length and saturation of the amide linked acyl chain. Liquid-
chromatography coupled to mass-spectrometry analysis (LC-MS) was 
performed on total lipids extracts of 661W cells, after 12 hours of stress. 
H2O2 did not significantly change total Cer but elicited its action modulating 
single species amount. On one hand, it significantly augmented long-chains 
Cer.s: 1.5 folds N-C16 acyl chain, 2.5 folds N-C18 acyl chain, 3 folds N-C20 
acyl chain species; on the other hand, a 50% decrease was showed for N-
C24 acyl chain Cer, the very long chains species analyzed (Fig. 5.6A). 
We also studied SD effect on Cer species discovering that it never caused 
Cer amounts raise but instead it decreased them. This is in accordance 
with the starvation shut down of any synthesis activity and/or autophagy 
promotion. Significant decrease was observed only for the total Cer.s, 
reduced of about 30% with respect to the control (Fig. 5.6B). 
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Fig. 5.6: Oxidative stress and serum deprivation change cellular Cer.s 
amount. Cells were stressed with 1mM H2O2 and 1% FBS DMEM for 12 hours. A-
B) Lipid extracts were analyzed for the quantification of total and six single Cer 
species (from N-C14 to N-C24 acyl chain Cer.s) by means of LC-MS. Cer amounts 
(picomoles) were normalized on milligrams of proteins and showed values were 
expressed as fold change vs control (Ctr), untreated cells. Data are obtained from 
three experiments and values are expressed as average ± SEM. Significance was 
analyzed through Student t-test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not 
significant. SD: serum deprivation  
 
5.4 THI lowers Cer contents in H2O2-challenged photoreceptors 
Given the antithetic role of Cer and S1P, we focused our study on 
ceramide-inducing oxidative stress, since SD did not alter Cer level. Two 
hours of 75µM THI pretreatment, followed by 1mM H2O2 for 12 hours, 
reduced Cer both as total level (25%) and almost all the single species. 
Regarding shorter-chain members, reductions were: 30-35% for N-C14 acyl 
chain and N-C18 acyl chain and 50% for N-C20 acyl chain species. THI 
significantly acted also on longer Cer, lowering of 30-35% both N-C22 acyl 
chain and N-C24 acyl chain elements (Fig. 5.7). 
 
Fig. 5.7: THI counteracts Cer H2O2-induced raise. Cells were pretreated with THI 
for two hours and stressed with 1mM H2O2. After 12 hours, lipid extracts were 
analyzed for the quantification of total and six different Cer.s (from N-C14 to N-C24 
acyl chain Cer.s) by means of LC-MS. Cer amounts (picomoles) were normalized 
on milligrams of proteins and showed values were expressed as fold change vs 
H2O2. Data are obtained from three experiments and values are expressed as 
average ± SEM. Significance was analyzed through Student t-test. *P < 0.05, **P < 
0.01, ***P < 0.001, n.s. not significant.   
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5.5 THI and H2O2 oppositely modulate S1P intracellular content 
Due to THI function as inhibitor of S1PL, we investigated S1P amounts 
changes, through LC-MS measurement, on treated and untreated 661W 
cells and we observed low but significant modulation induced both by THI 
and H2O2. In particular, THI promotes the accumulation of S1P with respect 
to the control (Fig. 5.8A) and, conversely oxidative stress induces a 40% 
decrease of its amount (Fig. 5.8B). Finally, we were not able to determine a 
significant change when 661W cells are pretreated with the inhibitor and 
then stressed with H2O2 (Fig. 5.8C). 
 
 
Fig. 5.8: THI and H2O2 act on S1P amounts. Cells were pretreated with THI for 
two hours and stressed with 1mM H2O2. After 12 hours, lipid extracts were 
analyzed for the quantification of S1P by means of LC-MS. S1P amounts were 
normalized on milligrams of proteins and showed values were expressed as fold 
change against Ctr or H2O2 depending on the treatment evaluated: A) THI vs Ctr; 
B) H2O2 vs Ctr and C) THI/H2O2 vs H2O2. Data are obtained from three 
experiments and values are expressed as average ± SEM. Significance was 
analyzed through Student t-test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not 
significant.  
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5.6 Oxidative stress increases apoptosis in 661W cells and activates 
Nrf2/HO-1 pathway 
To study the outcome of oxidative stress and above reported signaling in 
cone like cell line, we investigated on apoptosis in Cer accumulating cells 
after H2O2  treatment. First, we performed TUNEL assay after 12 hours of 
1mM H2O2 and obtained a 50% apoptosis above the baseline control cells, 
as evidenced in the corresponding immunofluorescence images below (Fig. 
5.9A). Next we investigated apoptosis mechanism and analyzed the 
cytosolic presence of the pro-survival Bcl-2 and the pro-apoptotic Bax. The 
relation between these two proteins, both Bcl-2 family members, is crucial 
in cell fate determination, indeed, while Bax-Bax homodimer induces 
apoptosis, Bcl-2-Bax heterodimer promotes survival signals [176]. The shift 
of their ratio expresses an ongoing apoptosis path, dominant Bcl-2 saves 
cells from death, whereas major Bax expression triggers to apoptosis. We 
performed Western blotting to quantify Bcl-2 and Bax. The ratio Bcl-2/Bax, 
observed under H2O2 treatment was decreased about four folds with 
respect to the control (Fig. 5.9B). 
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Fig. 5.9: Oxidative stress induces apoptosis in photoreceptors. Cells were 
stressed with 1mM H2O2 for 12 hours. A) TUNEL-assay was performed to estimate 
the apoptosis degree. Images show TdT-positive nuclei labeled with rhodamine 
(red) and counterstained-Hoechst 33258 nuclei (blue). Apoptotic cells percentage 
was expressed as average number of TdT-positive nuclei on total amount of nuclei 
present. B) Apoptosis was also investigated by quantification of Bcl-2/Bax ratio. 
Cell lysates were resolved by SDS-PAGE and immunoblotted with antibodies for 
Bcl-2 (26 kDa) and Bax (23 kDa). The two proteins were quantified by densitometry 
and their ratio was calculated and reported in graph as fold change vs control (Ctr) 
untreated cells; β-actin (43kDa) was showed as loading control. Western blot 
images are the most significant among those quantified. Data are obtained from 
three experiments, values are expressed as average ± SEM. Significance was 
analyzed through Student t-test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not 
significant. 
 
H2O2 toxicity is exerted by ROS induction within the cell. Intracellular 
survival response consists in the formation of antioxidant molecules that 
are released in colture medium. Their concentration can be evaluated by 
means of FRAP (Ferric reducing antioxidant power) test, which measures 
their ferric reducing power. H2O2-treated 661W cells revealed a 40% 
decrease of antioxidant-intrinsic power, after 12 hours treatment (Fig. 
5.10A). A key player of the antioxidant survival response is Nrf2. This latter 
is a transcriptional factor whose ubiquitination and proteolysis is impaired 
under oxidative stress leading to its transcriptional activation of ARE-
dependent genes, among which ROS defence related proteins, such as 
HO-1 [177]. To better understand the ongoing pathway, we investigated 
Nrf2/HO-1 activation in 661W cells treated with 1mM H2O2 . We performed 
a Western blotting quantifing Nrf2 at 12 hours and we noticed an initial 
increase of Nrf2 activation (Fig. 5.10B).  
Results 
63 
 
 
Fig. 5.10: Oxidative stress induced Nrf2 expression in 661W. Cells were 
stressed with 1mM H2O2 for 12 hours. A) Antioxidant compounds release in 
supernatant was analyzed by the FRAP test and expressed in FRAP value (µmoles 
Fe(II)/µg proteins) as fold change vs control (Ctr), untreated cells. B) Activation of 
antioxidant molecular pathways was studied through the densitometric analysis of 
Nrf2 Western blotting bands (57kDa) from total cell lysates. Values were 
normalized on the corresponding β-actin (43kDa) and expressed as fold change vs 
control (Ctr) untreated cells. Data are obtained from three experiments, values are 
expressed as average ± SEM. Significance was analyzed through Student t-test. 
*P < 0.05, **P < 0.01, ***P < 0.001, n.s. not significant. 
Finally, we analyzed HO-1 mRNA content by Real-Time PCR (RT-qPCR) at 
12, 24 and 48 hours and a potent induction (ten folds increase) of HO-1 
mRNA transcription was observed at the first time point. HO-1 transcript 
level decreases over time, side by side with cell demise (Fig 5.11). 
 
Fig. 5.11: Oxidative stress strongly upregulates HO-1 transcript expression at 
early time points. 661W were stressed with 1mM H2O2 for 12, 24 and 48 hours 
and mRNA expression level of HO-1 was analyzed by RT-qPCR. Data were 
normalized on GAPDH housekeeping gene and expressed as fold change vs 
control (Ctr), untreated cells. Data are obtained from three experiments, values are 
expressed as average ± SEM. Significance was analyzed through Student t-test. 
*P < 0.05, **P < 0.01, ***P < 0.001, n.s. not significant.   
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5.7 THI counteracts H2O2-induced apoptosis, eliciting its antioxidant 
action through additional activation of Nrf2 pathway 
To study the potential of THI and S1P accumulation and signaling in 
reducing oxidative-stress induced death in cone-like cells, we pretreated 
661W cells with THI 75 M for two hours and then treated them with H2O2 
1mM for 12 hours and studied cell death by TUNEL assay. TUNEL-stained 
cells reached 70% in H2O2 and decreased to 30% in THI/H2O2, as shown in 
the immunofluorescence images below (Fig. 5.12A). When looking at the 
molecular pathway involved, the Bcl-2/Bax ratio resulted increased by three 
folds in THI-protected cells, with respect to H2O2-traeted cells (Fig. 5.12B). 
 
 
Fig. 5.12: THI reduces photoreceptors apoptosis degree. THI Cells were 
pretreated with THI for two hours and stressed with 1mM H2O2 for 12 hours. A) 
TUNEL-assay was performed to estimate the apoptosis degree. Images show TdT-
positive nuclei labeled with rhodamine (red) and counterstained-Hoechst 33258 
nuclei (blue). Apoptotic cells percentage was expressed as average number of 
TdT-positive nuclei on total amount of nuclei present. B) Apoptosis was also 
investigated by quantification of Bcl-2/Bax ratio. Cell lysates were resolved by 
SDS-PAGE and immunoblotted with antibodies for Bcl-2 (26 kDa) and Bax (23 
kDa). Ratio of densitometry quantifications were calculated and reported in graph 
as fold change vs H2O2, β-actin (43 kDa) was showed as loading control. Western 
blot images are the most significant among those quantified. Data are obtained 
from three experiments, values are expressed as average ± SEM. Significance was 
analyzed through Student t-test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not 
significant. 
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Antioxidant-induced activity of THI was observed by FRAP analysis and 
appeared to be two folds augmented against stressed 661W, in collected-
colture media (Fig 5.13A). We also investigated if THI protection was due to 
modulation of endogenous survival response. Indeed we observed a further 
increase in Nrf2 accumulation and activation in THI/H2O2-treated cells with 
respect to 12 hours H2O2-stressed photoreceptors (Fig 5.13B).  
 
 
 
Fig. 5.13: THI increases antioxidant-intrinsic power of photoreceptors and 
potentiates Nrf2 expression. Cells were pretreated with THI for two hours and 
stressed with 1mM H2O2 for 12 hours A) Antioxidant compounds release in 
supernatant was analyzed by the FRAP test and expressed in FRAP value (µmoles 
Fe(II)/µg proteins) as fold change vs H2O2. B) Activation of antioxidant molecular 
pathways was studied through the densitometric analysis of Nrf2 protein bands 
(57kDa). Values were normalized on the corresponding β-actin (43kDa) and 
expressed as fold change vs H2O2. Data are obtained from three experiments, 
values are expressed as average ± SEM. Significance was analyzed through 
Student t-test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not significant. 
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Correspondingly, the antioxidant survival response was enhanced at 12 
hours and, in addition, it was prolonged and improved as showed by the 
maintenance of high levels of HO-1 transcript up to 48 hours (Fig 5.14). 
This observation is in accordance with THI recover from death, starting at 
12 hours and within the same time frame (see above, Fig. 5.3A). 
 
 
 
Fig. 5.14: THI enhances HO-1 transcription, over time, against oxidative 
stress. Cells were pretreated with THI for two hours, stressed with 1mM H2O2 for 
12 and 48 hours and mRNA expression level of HO-1 was analyzed by RT-qPCR 
and data were normalized on GAPDH housekeeping gene and expressed as fold 
change vs H2O2. Data are obtained from three experiments, values are expressed 
as average ± SEM. Significance was analyzed through Student t-test. *P < 0.05, 
**P < 0.01, ***P < 0.001, n.s. not significant.  
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5.8 S1P receptors expression in 661W cells 
Due to the scarcity of studies on S1P signaling in 661W cells, we could not 
find any evidence of S1P-receptors expression in this cell line. S1P is 
known to act as endogenous signaling mediator but also to be secreted by 
specialized pump and act in a paracrine fashion, via GPCR receptors 
engagement. Therefore we analyzed the expression, by RT-qPCR, of the 
known five isoforms of S1PRs in 661W cell line. We showed that the entire 
family of S1PRs was expressed in our cells, pointing out an almost 
decreasing linearity from the first to the last member (Fig. 5.15). 
 
Fig. 5.15: S1PR1-5 in photoreceptors. mRNA expression levels of all five S1PRs 
were analyzed by RT-qPCR, data were normalized to the endogenous GAPDH 
control gene and expressed as fold change vs the first receptor (S1PR1). Data are 
obtained from three experiments, values are expressed as average ± SEM. 
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5.9 THI and H2O2 influence S1P receptors transcripts expression  
To better understand the role and the power of THI on stressed 
photoreceptors, we evaluated the mRNA transcript modulation on 661W 
cells in presence of THI and H2O2-treatment. After THI stimulation the 
expression of the last two receptors, S1P4 and S1P5, was strongly 
upregulated, reaching about a four folds increase, instead of S1P1, S1P2 
and S1P3 that did not sense THI-effect (Fig. 5.16). 
 
 
Fig. 5.16: THI modulates S1P4 and S1P5 mRNA expression. Cells were treated 
with 75µM THI. mRNA expression levels of all five S1PRs was analyzed by RT-
qPCR, data were normalized on GAPDH housekeeping gene and expressed as 
fold change vs control (Ctr), untreated cells. Data are obtained from three 
experiments, values are expressed as average ± SEM. Significance was analyzed 
through Student t-test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not significant. 
 
On the contrary, 12 hours of oxidative stress produced a significant 
decrease of S1P3, S1P4 and S1P5 mRNA, in particular it halved their 
amounts. H2O2 did not have the same effect on S1P1 and S1P2 transcript 
expression and especially it did not affect S1P2 mRNA at all (Fig. 5.17)  
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Fig. 5.17: Oxidative stress affects S1P3, S1P4 and S1P5 mRNA expression. 
Cells were challenged with 1mM H2O2 for 12 hours. mRNA expression levels of all 
five S1PRs was analyzed by RT-qPCR, data were normalized on GAPDH 
housekeeping gene and expressed as fold change vs control (Ctr), unstressed 
cells. Data are obtained from three experiments, values are expressed as average 
± SEM. Significance was analyzed through Student t-test. *P < 0.05, **P < 0.01, 
***P < 0.001, n.s. not significant.  
 
We observed that THI cotreatment did not significantly change S1P2 and 
S1P3 transcript amounts with respect to that of oxidative stressed cells. 
Meanwhile, S1P1 mRNA was weakly incremented, S1P4 and S1P5 mRNA 
were highly upregulated showing a four folds and an eight folds increase 
respectively (Fig. 5.18).  
 
 
Fig. 5.18: THI counteracts H2O2 effect on S1P1, S1P4 and S1P5 mRNA 
expression. Cells were pretreated with THI for two hours and then with 1mM H2O2 
for 12 hours. mRNA expression levels of all five S1PRs was analyzed by RT-
qPCR, data were normalized on GAPDH housekeeping gene and expressed as 
fold change vs H2O2. Data are obtained from three experiments, values are 
expressed as average ± SEM. Significance was analyzed through Student t-test. 
*P < 0.05, **P < 0.01, ***P < 0.001, n.s. not significant.  
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5.10 Extracellular S1P rescues photoreceptors from oxidative stress  
Due to the above reported evidence of THI modulation of S1P1-5 receptors 
expression, we decided to investigate a possible paracrine action for the 
endogenously produced S1P in 661W rescue. 
Therefore we analyzed the effect of exogenously administered S1P. Cells 
were pretreated with 1µM and 100nM S1P for 1 hour, before oxidative 
stimulus, cell proliferation was assessed after 12, 24 and 48 hours through 
MTT assay. First we observed a strict dependence of receptor signaling on 
agonist concentration, as expected for GPCRs regulated by agonist 
inactivation. Whereas 1M S1P did not trigger protection against stress 
(Fig. 5.19A), S1P low concentration, 100 nM, reduced H2O2 induced arrest 
of proliferation, measured by MTT, at 12, 24 and 48 hours (Fig. 5.19B). To 
analyze cell viability, Trypan blue exclusion assay was performed after 1 
hour of 100nM S1P pretreatment and 12 hours of oxidative stress, 
percentage of live and dead cells was determined with respect to total cell 
number. The number of alive cells increased 25% and, at the same time, 
dead cells were diminished about three folds (Fig. 5.19C). 
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Fig. 5.19: Extracellular S1P counteracts H2O2 action. 1µM (A) and 100nM (B) 
S1P was added to cells, one hour before 1mM H2O2 and cells were analyzed after 
12, 24 and 48 hours from stress. Cell proliferation was evaluated by MTT assay. 
Data are expressed as fold change vs time zero (T0), against time. C) 
Photoreceptors viability, in presence of S1P, was assessed with Trypan blue 
exclusion assay after 12 hours of stress. Percentages of live and dead cells were 
calculated considering total cells as 100%. Data are obtained from three 
experiments and values are expressed as average ± SEM. Significance was 
analyzed through Student t-test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not 
significant. 
 
To assess a possible antioxidant-induced power of extracellular S1P 
against H2O2, FRAP assay was performed in collected-colture media. 
FRAP value obtained from S1P pretreated cells was significantly higher 
(two folds) in comparison with those from stressed photoreceptors (Fig. 
5.20).  
 
Fig. 5.20: Exogenous S1P improves antioxidant-intrinsic photoreceptors 
power. 100nM S1P was added to cells, one hour before 1mM H2O2 and cells were 
analyzed after 12 hours from stress. Antioxidant compounds release in supernatant 
was analyzed by the FRAP test and expressed in FRAP value (µmoles Fe(II)/µg 
proteins) as fold change vs H2O2. Data are obtained from three experiments and 
values are expressed as average ± SEM. Significance was analyzed through 
Student t-test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not significant. 
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5.11 Myriocin strongly affects Cer amounts as single treatment and 
with THI, both in unstressed and stressed cells 
S1P derives from the rupture of Cer amide linkage and the release of 
sphingosine and fatty acid. Sphingosine is immediately phosphorylated to 
avoid toxicity. Thus S1P may derive either from ceramide neo-synthesis or 
from ceramide release from sphingomyelin hydrolysis. In order to trace a 
possible contribution of ceramide de novo synthesis under oxidative stress, 
661W cells were pretreated with Myriocin, an inhibitor targeting the first and 
rate limiting step of ceramide biosynthesis pathway. 
THI did not affect significantly Cer amounts except for the shorter specie 
studied: N-C14 acyl chain. Myriocin, in single treatment but also in 
combination with THI, reduced four times total ceramides and 
downregulated all studied species: 50% reduction in N-C14 acyl chain and 
N-C18 acyl chain species, 60% in N-C20 acyl chain specie, 70% in N-C16 acyl 
chain and N-C22 acyl chain species and 90% in N-C24 acyl chain specie 
(Fig. 5.21) 
 
Fig. 5.21: Myriocin drastically decreases Cer.s amounts. 10µM Myriocin and 
75µM THI were added to cells. After 12 hours, lipid extracts were analyzed for the 
quantification of total and six single Cer species (from N-C14 to N-C24 acyl chain 
Cer.s) by means of LC-MS. Cer.s amounts (picomoles) were normalized on 
milligrams of proteins and values were expressed as fold change vs control (Ctr), 
unstressed cells. Data are obtained from three experiments and expressed as 
average ± SEM. Significance was analyzed through Student t-test. *P < 0.05, **P < 
0.01, ***P < 0.001, n.s. not significant.  
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Pretreatment of 661W with Myriocin, before oxidative stress with H2O2, 
induced a 50% reduction in Cer.s, affecting all fatty acyl species. As 
expected, THI combination with Myriocin did not alter Cer.s profile with 
respect to Myriocin only (Fig. 5.22). 
 
 
Fig. 5.22: Myriocin antagonises H2O2-induced increase of Cer.s.. 10µM 
Myriocin and 75µM THI were added to cells, five and two hours before 1mM H2O2. 
After 12 hours, lipid extracts were analyzed for the quantification of total and six 
single Cer species (from N-C14 to N-C24 acyl chain Cer.s) by means of LC-MS. 
Cer.s amounts (picomoles) were normalized on milligrams of proteins and values 
were expressed as fold change vs H2O2. Data are obtained from three experiments 
and expressed as average ± SEM. Significance was analyzed through Student t-
test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not significant. 
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5.12 Myriocin and Myriocin-THI treatments counteract oxidative stress 
effect on photoreceptors. 
In order to evaluate Myriocin effects on 661W cells, Trypan blue exclusion 
assay was performed, pretreatment with 10µM Myriocin for five hours 
before the addition of H2O2, or THI 75µM (2 hours) and then oxidative 
stress was carried on for other 12 hours. 75% inhibition of survival was 
obtained with H2O2 only (Fig. 5.23). Myriocin and Myriocin/THI treatments 
insured a recover of survival up to 90% and 95%, respectively, after 
oxidative stress. Accordingly, dead cells ratio lowered almost five times with 
both treatments. 
 
 
 
Fig. 5.23: Myriocin and Myriocin-THI recover 661W cells viability from 
oxidative stress.. 10µM Myriocin and 75µM THI was added to cells, five and two 
hours before 1mM H2O2. Cells were analyzed after 12 hours. Photoreceptors 
viability, in presence of inhibitors, was assessed with Trypan blue exclusion assay. 
Percentages of live and dead cells were calculated considering total cells as 100%. 
Data are obtained from three experiments and values are expressed as average ± 
SEM. Significance was analyzed through ANOVA followed by Bonferroni multiple 
comparisons, when P<0.05. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not significant. 
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Antioxidant-induced effect of Myriocin and THI on H2O2  stress was 
evaluated by means of FRAP assay, in colture media. Both Myriocin and 
Myriocin/THI induced two folds increase in antioxidant factors release with 
respect to H2O2 (Fig. 5.24). 
 
 
 
Fig. 5.24: Myriocin and Myriocin-THI have antioxidant-induced activity 
against H2O2. 10µM Myriocin and 75µM THI were added to cells, five and two 
hours before 1mM H2O2. Antioxidant compounds release in supernatant was 
analyzed by the FRAP test and expressed in FRAP value (µmoles Fe(II)/µg 
proteins) as fold change vs H2O2. Data are obtained from three experiments and 
values are expressed as average ± SEM. Significance was analyzed through 
Student t-test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not significant. 
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5.13 New synthetic compounds: SPT inhibitors 
In order to characterize new compounds with the same activity of Myriocin 
in inhibiting SPT, the rate limiting enzyme of the ceramide synthesis 
pathway, a number of compounds have been synthesized as potential 
inhibitors. Due to SPT internal membranes localization, enzymatic activity 
was evaluated in enriched fractions of microsomal membranes obtained 
from MDA-MB 231 cells. This cell line was chosen for its high proliferation 
rate and also basing on our laboratory experience, however it was 
previously employed to study SPT in vitro activity [178]. The enzyme 
inhibitory activity of 30 new compounds, developed from different backbone 
structures, was tested in vitro. We considered Myriocin incubation with 
microsomal membranes-SPT extract as positive control and DMSO 
incubation (vehicle of each compound) as 100% of SPT activity. At first, 
inhibitors were screened at a fixed concentration of 50µM, only the most 
promising molecules were selected and tested at scalar concentration to 
determine their IC50 value. 
From the first step screening, we found three active inhibitors on SPT: DC9, 
DC14 and DC80, that lowered the percentage of SPT activity to 5.68%, 
12.58% and 29.90% respectively. Therefore, we measured their IC50, 
resulting in: DC9 17.71µM, DC14 19.42µM and DC80 40.41µM (Tab. 5.1). 
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Compound name SPT activity ± SD (% vs DMSO) 
A7  139.35 ± 21.73  
A9  56.17 ± 3.24  
DC6  177.91 ± 8.59  
DC9  5.68 ± 2.15  
DC10  81.65 ± 10.81  
DC11  157.63 ± 1.77  
DC12  153.83 ± 10.50  
DC13D  87.92 ± 5.63  
DC14 12.58 ± 2.08  
DC20A  102.26 ± 14.38  
DC21A  94.85 ± 5.93  
DC25A  98.26 ± 4.68  
DC46B  118.85 ± 3.02  
DC50A  116.76 ± 11.27  
DC63C  103.47 ± 4.64  
DC70  108.45 ± 1.25  
DC71  105.11 ± 5.01  
DC74  123.16 ± 6.40  
DC79  92.8 ± 3.49  
DC80  29.9 ± 9.46  
DC81  65.58 ± 2.23  
DC82  58.9 ± 5.35  
PR1  92.22 ± 3.61  
PR2  106.99 ± 4.19  
RB6  104.68 ± 8.66  
RB7  77.83 ± 4.79  
RB8  42.69 ± 1.74  
RB17  106.56 ±0.36  
RB19  59.6 ± 3.94  
RB20  94.24 ± 6.80  
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Compound name IC50 ± SD (µM)  
DC9  17.71 ± 1.00  
DC14  19.42 ± 4.98  
DC80  40.41 ± 4.77  
 
Tab. 5.1: Comparative analysis of the 30 compounds tested for SPT. Synthetic 
compounds were tested on SPT activity at 50µM and their inhibition power was 
indicated as percentage of SPT activity considering DMSO incubation as 100%. 
Three of them, that showed a remaining percentage of enzymatic activity under 
30%, were analyzed to determine their IC50. Data are obtained from three  
experiments and values are expressed as average ± SD 
. 
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This study aims at demonstrating the involvement of sphingolipids in 
photoreceptor death, suggesting the manipulation of this signaling 
molecules as potential therapeutic targets in retinal diseases. In particular, 
we worked on a stressed cone-like cell line as a model of cone 
photoreceptors degeneration. In RP, cones photoreceptors degeneration is 
secondary to rods damages and it occurs mainly as bystander effect. This 
makes this process suitable for therapeutic approaches aimed at reducing 
the potency of stress insults on viable cones.  
In spite of rods degeneration and considering the importance of cones 
preservation to allow minimal daily vision, the purpose of our study is to 
increase intracellular S1P concentration through the inhibition of SPL, the 
enzyme responsible for one of the two degradation pathway. 
 
The cone-like cell line, 661W, is a unique in vitro model of photoreceptors, 
derived from mouse retinal tumours [47]. In the intent to investigate the 
possibility to activate salvage pathways of these photoreceptors, we 
subjected 661W cells to two different kind of stress: oxidative stress by 
means of H2O2 and ischemia-like condition throughout serum deprivation 
(SD). Due to their different nature, these two stresses produced distinct 
effects, evidenced in cell proliferation measurement over time. In Fig.5.1A 
and B, we showed, on one side, how H2O2 effect was pronounced causing 
apoptosis in a large part of the population whereas a small fraction of cells 
remained viable and proliferating, proportionally to the control rate. On the 
other side, we observed that SD progressively reduced cellular proliferation 
rate over time. Hence the two stress are sensed differently and may 
activate diverse stress responses: oxidative stress can be considered an 
acute and intense stimulus, partially overcome by a small number of 
resistant and growing cells; SD fails to select resistant cells, and slowly 
affects the entire population because of continuous lack of necessary 
nutrients, such as growth factors. 
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First of all, we considered cellular viability at the 12 hours time point (Fig. 
5.1C). Both stresses resulted in a strong decrease of live cells and in a 
parallel augment of death at this early time point. To understand the 
intracellular pathways involved, we chose two well known proteins with 
pivotal role in cells proliferation and survival, ERKs and Akt. The 
ERK/MAPK pathway activation is often linked to proliferation and survival in 
both in vitro and in vivo models [179]. Particularly ERKs activation in rat 
retina was associated to protection against light injury [180], as well as in 
661W cell colture under short stimulation with H2O2 (30 minutes). Although 
an initial survival response is triggered by the cells, if stress is sustained in 
time, cell demise will finally follow [181]. Accordingly, we observed that 12 
hours of H2O2 treatment or SD cause cell death and ERKs 
dephosphorylation (Fig. 5.2A). Another important player in survival 
responses is the kinase Akt/PKB, whose activity is modulated during 
pathological situations [182] such as retinal degeneration, indeed Akt 
activation was demonstrated to rescue rat retinal neurons from light-
induced apoptosis [183]. Cotter’s group showed, in 661W, that serum 
deprivation induced a rapid but detectable burst of H2O2, activating survival 
pathways and promoting Akt phosphorylation, at Thr408 [184]. Years later 
the same group demonstrated that bFGF administration to 661W enhanced 
ROS production and again Akt phosphorylation occurred, even if on Ser473 
[185], the same phosphorylation was documented in H2O2- stressed RPE 
[175]. Another group demonstrated that, in a different stress and cellular 
model, the site of Akt phosphorylation changed depending on the severity 
of the stress: Ser473 phosphorylation was associated to an early stress 
meanwhile Thr408 corresponded to intense and prolonged stress [186]. 
Our results confirmed that oxidative stress, as well as SD, induced Akt 
activation that resulted in Ser473 phosphorylation (Fig. 5.2B). In our model 
Akt activation persisted with respect to that on ERK suggesting a potential 
regulation of Akt in switching off of the ERK pathway. 
Discussion  
82 
 
S1P is a well-know anti-apoptotic sphingolipid able to induce cell survival, 
proliferation and differentiation in several cell lines and tissues [83]. 
Furthermore, S1P was recognized to participate in photoreceptors 
protection against oxidative stress [163]. In order to investigate a potential 
role of S1P in rescue 661W from death-induced stimuli, we treated cells 
with THI, SPL inhibitor, at the aim of increasing the endogenous amount of 
S1P. Inhibitory effect of this compound is mainly used in studies on 
autoimmune disorders. Due to its ability to accumulate S1P, THI induces its 
gradient deregulation that consequently leads to lower levels of circulating 
peripheral lymphocytes [150]. In our study we treated cells with THI 2 hours 
prior to H2O2 (1mM) and contemporarily with SD. THI pretreatment was 
able to reduce stresses inhibition of proliferation from 12 up to 48 hours of 
treatment (Fig. 5.3A and B). Moreover THI exerted a protective effect on 
cell death, increasing the number of viable cells in both starved and H2O2 
stressed samples (Fig. 5.3C and D). To analyze the correlation between 
intracellular S1P and survival intracellular signaling [187], the activation 
state of ERK and Akt was analyzed under THI action. In both cases the 
inhibitor was able to counteract stress effects, on one side by inducing the 
activation of switched-off ERK 1 and 2 (Fig. 5.4A), on the other side by 
decreasing stress-induced phosphorylation on Akt (Fig. 5.4B). Confirming a 
potential cross-talk between these two pivotal survival regulators, in which 
one regulates the other depending on the stress severity and likely also on 
the site of Akt phosphorylation. 
By comparing the two stresses, serum deprivation did not effectively killed 
cells but rather stopped them slowing their proliferation. Such a difference 
was also evidenced in Cer species quantification. Considering that Cer is a 
well-known apoptotic signaling mediator whose cellular content increases 
upon stress [188] and that its involvement in oxidative stress-induced 
apoptosis was also documented in photoreceptors [52], we evaluated Cer 
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content by LC–MS analysis and we observed different profile of Cer.s pools 
under the two stresses. H2O2, which is a direct and immediate ROS 
mediated damage inducer, causing mitochondria failure and triggering a 
rapid apoptotic response, induced an augment in long-chain Cer (16:0, 
18:0, 20:0 and 22:0), known as pro-apoptotic species [73]. At the same 
time, it produced a decrease in the very long-chain Cer 24:0. Given that 
Cer 16:0 and 24:0 are the most abundant species, the total level of Cer 
resulted unchanged overall. (Fig. 5.6A). SD did not induce any augment in 
Cer content, on the contrary we observed that all the species were reduced 
(Fig. 5.6B), according to the necessity to slow down all energy consuming 
processes, including sphingolipids synthesis. 
The evidences that oxidative stress directly influences sphingolipid pathway 
and, in particular, Cer which is the hub of all the biosynthetic chain, led us 
to focus our investigation mainly on this kind of stress. Before deepening in 
biochemical mechanisms, we investigated the influence of THI 
pretreatment on H2O2-stressed photoreceptors, observing that the inhibitor 
had a significant effect on Cer quantities and succeeded in lowering, not 
only almost all Cer species analyzed, but also total Cer, because of its 
indiscriminate action upon different chain-length species (Fig. 5.7). 
 
Furthermore, we investigated S1P amounts modulation under THI and 
H2O2 treatment. Intracellular S1P detection is not easily feasible in 
comparison with others sphingolipids, given both its low concentration 
inside the cells and its rapid degradation by means of SPL and 
phosphatases, although we succeeded in evidencing significant modulation 
of S1P. In particular, on one side THI treatment promoted S1P raise in 
photoreceptors (Fig. 5.8A) and on the other side oxidative stress induced 
its decrease (Fig. 5.8B). Whereas the inhibitor pretreatment on stressed 
cells did not produce a sufficient effect, indeed S1P increase against 
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challenged photoreceptors resulted to be not significant, likely due to 
abovementioned difficulties in its detection (Fig. 5.8C) 
 
Due to the fact that pro-death Cer species increased under oxidative stress 
and declined in the presence of THI, we investigated apoptosis by TUNEL 
assay observing, as expected, that the percentage of apoptotic 
photoreceptors increased after 12 hours of H2O2 (Fig. 5.9A). Next, we 
analyzed and compared the protein expression of two Bcl2 family members 
with opposed roles: Bcl2, an anti-apoptotic marker, and Bax, a pro-
apoptotic one [189]. Apoptosis decrease during retinal development [190] 
or pharmacological impairment of apoptosis in retina [191] was previously 
demonstrated to associate with pro-death Bcl-2 proteins content.  
Our data, in line with literature, showed a decrease in Bcl2/Bax ratio 
translating in a predominant relative amount of Bax that could be 
associated to the apoptosis degree observed with the immunofluorescence 
test (Fig. 5.9A and B). 
By means of FRAP test, a commonly employed method to investigate 
plasma reducing power [192], we observed that 12 hours of H2O2 
decreased the amount of reduced iron, that in turn is associated with a 
diminished release of antioxidant molecules in the colture medium and 
hence in augmented oxidative stress in cells (Fig. 5.10A).  
In order to elucidate the mechanism underlying photoreceptors responses 
to oxidative stress, we investigated the activation of the nuclear factor 
erythroid 2 (NFE2)-related factor 2, Nrf2. The latter is a transcription factor 
with a fundamental role in cell resistance to oxidative stress. In basal 
condition its activity is suppressed by Keap1 protein (Kelch-like ECH-
associated protein 1) through a continuous ubiquitination-proteasomal 
degradation that is suspended by the action of oxidants and electrophiles, 
via modification of Keap1 critical cysteine thiols groups and release of Nrf2 
[177]. Nrf2 role in 661W cells protection to oxidative stress was previously 
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observed [193]. Similarly, our data showed a weak however significant 
increase of Nrf2 expression after H2O2 treatment (Fig. 5.10B). When Nrf2 is 
activated it translocates into the nucleus, where its binding to antioxidant-
responsive elements (AREs), stimulates the transcription of phase II genes 
encoding detoxifying and antioxidant enzymes, such as heme oxygenase-1 
(HO-1) [194]. HO-1 protective induction was previously documented in 
661W cells [66] [51]. In order to identify a possible involvement of HO-1 
activation, in Fig. 5.11, we analyzed its transcript and observed that an 
increased transcription is associated with early survival response to stress, 
but after 24 and 48 hours HO-1 mRNA levels fall down in association with 
cell death progression.  
In order to elucidate THI protective mechanism, we investigated the effect 
of its pretreatment on the above studied signaling mediators. As previously 
shown, DHA-induced protection of photoreceptors death was attributed to 
the increased of Bcl2-Bax ratio likely induced by ERK/MAPK activation 
[195]. Furthermore Bcl2 overexpression was demonstrated to rescue 661W 
cells from photoxidative stress [24] and to counteract photoreceptors 
apoptosis in different retinal degenerations [196]. Additionally, in Jurkat 
cells, S1P inhibition of the pro-apoptotic Bax and Bad activation, was 
supposed to be caused by MEK activation [197]. 
In our hands, THI pretreatment was able to reduce apoptosis, decreasing 
the number of TUNEL-stained cells with respect to only stressed cells (Fig. 
5.12A). Simultaneously Bcl2 expression augmented up to overtake that of 
Bax, shifting their ratio equilibrium in favour to survival stimulus and proving 
that the inhibition of S1P degradation has a role in preserving 661W cells 
from apoptosis (Fig. 5.12B). Moreover, THI showed an antioxidant activity 
against H2O2, augmenting the FRAP value (Fig. 5.13A) and further 
stabilizing Nrf2 protein in stressed cells (Fig. 5.13B), thus supporting the 
hypothesis of a critical role of the transcription factor in cells protection. In 
THI and H2O2 treated cells, HO-1 transcription was protracted, in 
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accordance with Nrf2 stabilization. Whereas after 48 hours of H2O2 HO-1 
transcription was repressed, in THI pretreated cells the transcript is still 
present at high levels, likely as a part of the THI induced survival response, 
the higher difference was at 48 hours (Fig. 5.14). We can conclude that one 
of the downstream effect of THI is to strengthen the action of detoxification 
enzymes. This may be imputable to an indirect S1P antioxidant induction 
against oxidative stress, resulting in an enriched response of detoxifying 
pathways. Similarly, in a rat model of emphysema, S1P ability to 
overexpress Nrf2 against stress was previously showed [198], in addition 
Nrf2 was showed to protect human RPE cells from H2O2-induced oxidative 
stress via Nrf2-mediated upregulation of the expression of phase II 
enzymes involving the PI3K/Akt pathway [199]. Furthermore HO-1 
induction protected retinal ganglion cells in diabetic retinopathy [200], even 
if it was also demonstrated that decreased expression of HO-1 was 
observed in treatments with molecules that acted as direct scavengers 
against H2O2 [201]. 
 
Given S1P duality as intracellular messenger and extracellular ligand and 
its well-know ability to exit the cell through specific transporters [202], we 
hypothesized that THI, by means of S1P accumulation, could interact or 
modulate S1PRs. To the best of our knowledge, the expression of S1PRs 
has not been proven in 661W cell line. Analyzing S1P1-5 mRNA we 
confirmed their expression in our cellular model and underlined different 
and proportional decreasing degree of receptor’s expression. In particular, 
S1P1 resulted to be the more abundant member, followed by S1P2, 
whereas S1P3-5 showed the lowest expression (Fig. 5.15). S1PRs belong 
to the family of GPCR proteins, they are coupled to different G-proteins 
and, for this reason, their influence on cells behaviour widely changes 
[110].  
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Preliminary data on THI effect on S1PRs expression showed an interesting 
tendency in a preferential modulation of S1P4 and S1P5. THI alone 
increased both mRNA receptors and did not significantly alter S1P1-3, 
especially for what concerned the second receptor (Fig. 5.16). In contrast, 
oxidative stress had a negative influence on transcript amounts, powerfully 
acting on S1P3-5, as emerged from Fig. 5.17. THI pretreatment on 
stressed photoreceptors strongly overexpressed S1P4 and S1P5 and 
showed a weak however significant activity also on S1P1 (Fig. 5.18). In 
conclusion S1P2 resulted to be the only member of S1PRs family, in 661W, 
that was affected neither by THI nor by oxidative stress effects. All these 
observations, although they must be further confirmed, have to be 
considered interesting and significant in the global vision for putative THI 
purpose in visual and, in particular, neural-retinal pathologies, opening the 
possibility of new therapeutic strategies. Therefore, we distinguished a 
double THI effect in antagonizing oxidative stress: firstly, its action on cell 
proliferation, viability, apoptosis and oxidant power and, secondly, its ability 
to modulate S1PRs expression in unstressed and stressed photoreceptors. 
 
Given the interesting modulation of S1PRs in our in vitro model, we 
investigated the involvement of exogenous S1P in 661W cells rescue from 
oxidative stress. Cells were pretreated for 1 hour with S1P at 1µM and then 
challenged with H2O2 1mM for 12, 24 and 48 hours. Exogenously added 
S1P did not show significant cellular proliferation improvement against 
oxidative stress (Fig. 5.19A). Being GPCR, S1PRs underwent 
desensitization via temporary or β-arrestin-induced internalization upon 
massive engagement by respectively S1P or its potent agonists [111]. As a 
matter of fact, lowering exogenous S1P concentration to 100nM, we 
obtained a remarkable rescue from cellular proliferation arrest upon 
oxidative stress (Fig. 5.19B). We confirmed that low S1P concentration 
increased cell viability after 12 hours of oxidative stress, (Fig. 5.19C). In line 
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with previous investigations, we measured FRAP value after S1P treatment 
obtaining an augment in antioxidant induced power respect to stressed 
cells (Fig. 5.20). 
 
To strengthen our hypothesis on the pivotal role of sphingolipids in 
photoreceptors fate and on the importance of their biosynthetic pathway 
manipulation, as a tool in contrasting retinal degeneration, we focused on 
Cer modulation employing a potent inhibitor of its de novo synthesis, 
Myriocin. This inhibitor was, previously, employed in vivo by our group 
demonstrating that inhibition of Cer de novo synthesis is able to rescue 
photoreceptors from degeneration, in a RP murine model [143]. We 
hypothesized that inhibition of Cer generation and increase of S1P 
intracellular content may be combined in the intent of improving cell 
protection. At this aim cells were treated with Myriocin (10 µM) also in the 
presence of THI (75 µM) for 5 hours and then H2O2 (1mM) was added for 
other 12 hours. LC-MS analysis confirmed that Myriocin drastically reduced 
all Cer species (Fig. 5.22), suggesting that de novo synthesis of Cer is 
majorly involved in oxidative stress in 661W. Unexpectedly, the 
combination of the two inhibitors failed to allow additive protection from cell 
death (Fig. 5.23); moreover it did not increase the production of antioxidant 
molecules (Fig. 5.24) under H2O2 treatment. This data lead to hypothesize 
that S1P protection and Cer induced apoptosis signal through pathways 
that are somehow interconnected, as indicated by THI modulation of some 
Cer species. 
THI is supposed to interact with PLP, the SPL cofactor, blocking its normal 
involvement in enzymatic mechanism to degrade S1P [149]. This 
hypothesis is supported by the evidence of vitamin B6 opposition to THI 
effect [154]. In our case, due to the pivotal role of PLP in SPT activity, this 
should be an explanation for decreased Cer amounts that we observed in 
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THI pretreated cells, even if significant modulation was registered only after 
oxidative stimulus (Fig. 5.21). This last observation together with the recent 
hypothesis defining SphK-1 and SphK-2 as regulators of de novo Cer 
synthesis [99], suggest the existence of a feedback action of S1P on Cer 
synthesis as previously demonstrated for phosphorylated long-chain 
sphingoid bases [203]. Oxidative stress induced apoptotic Cer generation. 
However, in THI pretreated cells, accumulated S1P modulates Cer, 
triggering their decrease. Both hypothesis look to the de novo pathway 
rather than to the salvage one, especially if we consider THI similitude to 
Myriocin in the indiscriminately way to induce Cer amount modulations. 
The pivotal role of Myriocin SPT inhibition in physiological and pathological 
states was demonstrated. Given the high cost of this inhibitor, we screened 
30 new synthesized compounds as putative SPT inhibitors. We were able 
to evidenced three molecules that led to a residue SPT activity equal to, at 
least, 30%. The IC50 of these new inhibitors was calculated (Tab. 1). Even 
if Myriocin effect remains incomparable, the identification of putative new 
structures leaves the way open to further investigations. An important 
association is underlined between some functional groups and the increase 
of SPT activity. To date, this trend is noticed in 4 compounds (A7, DC6, 
DC11 and DC12). This analysis is still ongoing in our laboratories. 
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In conclusion S1P endogenous increase, obtained with THI treatment, 
favours survival and proliferation upon stresses in an in vitro model of 
photoreceptor degeneration. S1P effect, against oxidative stress, is linked 
to some crucial intracellular pathways involved in cell fate regulation. 
Indeed, it modulates ERK and  Akt activation, Bcl-2/Bax equilibrium, Nrf2-
HO-1 expression and reduced intracellular Cer amounts (Fig. 7.1). 
 
 
 
Fig. 7.1: Conclusion scheme. THI accumulation of S1P induces decrease of 
apoptotic Cer and activates intracellular survival pathways. 
 
From our preliminary data, we can also conclude that THI-induced increase 
of S1P influences S1PRs expression. In addition, to confirm a 
supplementary role of extracellular S1P, we show that low exogenous S1P 
counteracts the inhibition of photoreceptors proliferation and viability 
induced by oxidative stress. Moreover, the cotreatment with inhibitors of 
sphingolipid synthesis and degradation, reducing Cer and increasing S1P 
intracellular content, is able to ensure survival in response to oxidative 
stress, even if the hypothesized  addictive effect was not observed. 
All these outcomes together demonstrate and confirm sphingolipid 
biosynthetic pathway as a paramount target in therapeutic approaches for 
photoreceptor degeneration. 
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